%PDF-1.3
%âãÏÓ
1 0 obj
<<
/OPM 1
/Type/ExtGState
>>
endobj
2 0 obj
<<
/FL 1
/SM 0.01
/Type/ExtGState
>>
endobj
3 0 obj
<<
/Length 10045
>>
stream
/GS0 gs
q
0 0.89 595 841 re
W n
1 g
0 841.89 0 0 re
f
Q
/GS1 gs
q
0 0 0 0 k
56.693 623.126 481.89 105.378 re
f
Q
q
BT
/F0 1 Tf
20 0 0 20 57.6929 712.5873 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Tubal sterilizasyonda elektrokoag\237lasyon ve mekanik )Tj
0 -1.1 TD
(klips y\232ntemlerinin over rezervine etkilerinin )Tj
T*
<6B6172DFDD6C61DF74DD72DD6C6D6173DD>Tj
ET
Q
q
BT
/F0 1 Tf
10 0 0 10 57.6929 629.5873 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Necdet S\206ER (*), Lale T\206RKGELD\334 (*), Furkan KAYABA\336O\332LU (*))Tj
ET
0 J 0 j 10 M []0 d 1 w
0 0 0 1 K
56.693 615.288 m
538.583 615.288 l
S
0 0 0 0 k
56.693 119.055 481.89 28.843 re
f
Q
q
BT
/F0 1 Tf
8 0 0 8 57.6929 140.6344 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(G\232nderilme tarihi:)Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 124.3374 140.6344 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(20.10.2008)Tj
ET
Q
q
BT
/F0 1 Tf
8 0 0 8 57.6929 131.6344 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Kabul tarihi:)Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 104.8003 131.6344 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(27.11.2008)Tj
-5.88842 -1.125 TD
(SB \334stanbul G\232ztepe E\333itim ve Ara\337t\335rma Hastanesi, Kad\335n Hastal\335klar\335 ve Do\333um Klini\333i, Dr.*)Tj
ET
0 J 0 j 10 M []0 d 1 w
0 0 0 1 K
57.78 755.355 m
539.669 755.355 l
S
0 0 0 0 k
56.693 748.851 481.89 17 re
f
Q
q
BT
/F0 1 Tf
10 0 0 10 57.6929 757.021 Tm
0 Tr
0 0 0 1 k
0.1 Tc
0 Tw
(KL\334N\334K ARA\336TIRMA )Tj
ET
Q
q
BT
/F2 1 Tf
10 0 0 10 488.6928 757.021 Tm
0 Tr
0 0 0 1 k
0.1 Tc
0 Tw
(Jinekoloji)Tj
ET
0 J 0 j 10 M []0 d 1 w
0 0 0 1 K
56.693 748.351 m
538.583 748.351 l
S
56.693 771.024 m
538.583 771.024 l
S
0 0 0 0 k
56.693 156.575 481.89 125.048 re
f
Q
q
BT
/F1 1 Tf
11 0 0 11 57.6929 272.01 Tm
0 Tr
0 0 0 1 k
0 Tc
0.091 Tw
(D\237nya genelinde kal\335c\335 kontrasepsiyon y\232ntemleri)Tj
0 -1.27273 TD
0.015 Tc
0.109 Tw
(aras\335nda en s\335k kullan\335lan metot tubal sterilizas-)Tj
0 -1.27272 TD
0 Tc
0 Tw
(yondur )Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 92.8502 246.6501 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
((1))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 102.1745 244.0101 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(.)Tj
0.61319 0 Td
0 Tc
0.113 Tw
(1995 ile 2000 y\335llar\335 aras\335nda yakla\337\335k)Tj
-4.65697 -1.27273 TD
0.088 Tw
(700 bin kad\335n\335n istenmeyen gebeli\333e ba\333l\335 oldu\333u)Tj
T*
0.112 Tw
(ger\215egi g\232z \232n\237ne al\335nd\335\333\335nda kontraseptif metot-)Tj
0 -1.27272 TD
0.093 Tw
(lar\335n \232nemi daha iyi anla\337\335labilir. Tubal sterilizas)Tj
20.19193 0.00001 TD
(-)Tj
-20.19193 -1.27274 TD
0.014 Tc
0.111 Tw
(yon, bir \215ok geli\337mekte olan \237lkede oldu\333u gibi)Tj
0 -1.27273 TD
0.023 Tc
0.102 Tw
(T\237rkiye\325de de s\335k kullan\335lan bir kontrasepsiyon)Tj
T*
0.01 Tc
0 Tw
(y\232ntemdir )Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 108.0571 162.65 Tm
0 Tr
0 0 0 1 k
0.01 Tc
0 Tw
((2))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 117.6306 160.01 Tm
0 Tr
0 0 0 1 k
0.0103 Tc
(.)Tj
0.63523 0 Td
0.01 Tc
0.115 Tw
(ABD\325de bu cer)Tj
6.47229 0.00001 TD
[(rahi pro)-1(sed\237r y\335lda)]TJ
10.54525 10.18181 TD
0.015 Tc
0.11 Tw
[(yar\335m milyonun \237zerin)-1(de \215ifte uygulanmaktad\335r.)]TJ
0 -1.27273 TD
0 Tc
0.042 Tw
[(Bunlardan yar\335)-1(s\335, do\333umdan hemen sonra, geri ka-)]TJ
0 -1.27272 TD
0.063 Tw
[(lan\335 ise elektif \337art)-1(larda ger\215ekle\337ti)-1(rilmektedir. Yi)-1(-)]TJ
0 -1.27273 TD
0.015 Tc
0.109 Tw
(ne ABD\325de 15-44 ya\337lar aras\335nda on bir milyon)Tj
T*
0.03 Tc
0.095 Tw
[(kad\335n, gebeli)-1(\333in \232nlenmesi icin do\333um kontrol)]TJ
0 -1.27272 TD
0 Tc
0 Tw
(y\232n)Tj
1.5 0.00001 TD
(te)Tj
0.72168 0.00001 TD
0.073 Tw
(mi ola)Tj
2.6004 0.00001 TD
(rak tu)Tj
2.3775 0.00001 TD
(bal ste)Tj
2.65532 0.00001 TD
0 Tw
(ri)Tj
0.61059 0.00001 TD
0.073 Tw
[(lizas)-1(yonu tercih etmi\337tir.)]TJ
-10.4655 -1.27276 TD
0.052 Tw
[(D\237nya genelinde 190 mil)-1(yondan daha fazla say\335da)]TJ
0 -1.27273 TD
0.002 Tc
0.123 Tw
(\215ift, g\237)Tj
2.9741 0.00001 TD
0 Tw
(ven)Tj
1.45106 0.00001 TD
0.123 Tw
(li ve ka)Tj
3.20778 0.00001 TD
[(l\335c\335 bir do\333um kon)-1(trol yontemi)]TJ
-7.63294 -1.27274 TD
0.055 Tc
0 Tw
(ola)Tj
1.38698 0.00001 TD
0.07 Tw
[(rak steri)-1(lizasyonu tercih etmekte)-1(dirler )]TJ
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 524.1862 162.65 Tm
0 Tr
0 0 0 1 k
0.055 Tc
0 Tw
((3))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 534.8329 160.01 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
ET
0 0 0 0 k
56.693 300.331 481.89 303.683 re
f
Q
q
BT
/F0 1 Tf
9 0 0 9 158.0741 595.9962 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
<85>Tj
0.77794 0.00001 TD
0 Tc
0 Tw
(ZET)Tj
ET
Q
q
BT
/F3 1 Tf
9 0 0 9 57.6929 575.9963 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Ama\215:)Tj
ET
Q
q
BT
/F2 1 Tf
9 0 0 9 85.546 575.9963 Tm
0 Tr
0 0 0 1 k
0 Tc
0.123 Tw
(Laparoskopik tubal sterilizasyon uygulanan hastalar-)Tj
-3.09479 -1.11112 TD
0.011 Tc
0.114 Tw
(da elektrokoagulasyon ve mekanik klips y\232ntemlerinin over)Tj
0 -1.11111 TD
0 Tc
0 Tw
(rezervine etkilerini kar\337\335la\337t\335rmak)Tj
ET
Q
q
BT
/F3 1 Tf
9 0 0 9 57.6929 535.9962 Tm
0 Tr
0 0 0 1 k
0.004 Tc
0 Tw
(Metodoloji:)Tj
ET
Q
q
BT
/F2 1 Tf
9 0 0 9 104.497 535.9962 Tm
0 Tr
0 0 0 1 k
0.004 Tc
0.121 Tw
(Bu prospektif randomize \215al\335smaya tubal steril-)Tj
-5.20046 -1.11111 TD
0 Tc
0.119 Tw
(izasyon arzusu olan reprod\237ktif \215a\333da 80 hasta dahil edildi.)Tj
T*
0.068 Tw
(Basit randomizasyon ile hastalar elektrokoagulasyon y\232ntemi)Tj
0 -1.11112 TD
0.089 Tw
(ile tubal sterilizasyon yap\335lanlar ve mekanik klips yontemiyle)Tj
0 -1.11111 TD
0.005 Tc
0.12 Tw
(tubal sterilizasyon yap\335lanlar olmak \237zere iki gruba ayr\335ld\335.)Tj
T*
0.002 Tc
0.123 Tw
(Preoperatif d\232nemde ve postoperatif 10. ayda elde edilen 3.)Tj
T*
0 Tc
0.048 Tw
(g\237n bazal serum FSH, LH, estradiol, inhibin-B, antimullerian)Tj
T*
0.036 Tc
0.089 Tw
(hormon, total bazal over hacim \232l\215\237m\237 ve antral folikul)Tj
T*
0 Tc
0 Tw
(say\335lar\335 her bir grup i\215inde ve gruplar aras\335nda kar\337\335la\337t\335r\335ld\335. )Tj
ET
Q
q
BT
/F3 1 Tf
9 0 0 9 57.6929 435.9962 Tm
0 Tr
0 0 0 1 k
0.002 Tc
0 Tw
(Bulgular:)Tj
ET
Q
q
BT
/F2 1 Tf
9 0 0 9 97.7099 435.9962 Tm
0 Tr
0 0 0 1 k
0.002 Tc
0.123 Tw
(Elektrokoagulasyon y\232ntemiyle tubal sterilizasyon)Tj
-4.44633 -1.11111 TD
0 Tc
0.037 Tw
(ve mekanik klipsle tubal sterilizasyon gruplar\335 aras\335nda, post-)Tj
T*
0.051 Tw
(operatif 10. ay total bazal over hacmi ve antral folikul say\335m\335)Tj
0 -1.11112 TD
0 Tw
(a\215\335s\335ndan anlaml\335 farklar izlendi.)Tj
ET
Q
q
BT
/F3 1 Tf
9 0 0 9 57.6929 385.9962 Tm
0 Tr
0 0 0 1 k
0.016 Tc
0 Tw
(Sonu\215:)Tj
ET
Q
q
BT
/F2 1 Tf
9 0 0 9 88.4601 385.9962 Tm
0 Tr
0 0 0 1 k
0.016 Tc
0.108 Tw
(Elektrokoagulasyon y\232ntemi ile laparoskopik tubal)Tj
-3.41858 -1.11111 TD
0 Tc
0.113 Tw
(sterilizasyonun postoperatif d\232nemde over rezervine olumsuz)Tj
T*
0 Tw
(etkileri oldu\333u d\237\337\237n\237lmektedir.)Tj
ET
Q
q
BT
/F3 1 Tf
9 0 0 9 57.6929 305.9963 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Anahtar kelimeler:)Tj
ET
Q
q
BT
/F2 1 Tf
9 0 0 9 130.6839 305.9963 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Tubal sterilizasyon, over rezervi )Tj
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 400.706 596.3016 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(SUMMARY)Tj
-8.2898 -2.22222 TD
(The influence of electrocoagulation and mechanical )Tj
-0.00037 -1.11112 TD
(clipping on reservation of over in tubal sterilization)Tj
ET
Q
q
BT
/F3 1 Tf
9 0 0 9 311.811 546.3016 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Objective:)Tj
ET
Q
q
BT
/F2 1 Tf
9 0 0 9 351.7014 546.3016 Tm
0 Tr
0 0 0 1 k
0 Tc
0.019 Tw
(To compare the effects of laparoscopic tubal steril-)Tj
-4.43226 -1.11112 TD
0.027 Tc
0.098 Tw
(ization through electrocoagulation and the application of)Tj
0 -1.11111 TD
0 Tc
0 Tw
(mechanical clips on the ovarian reserve.)Tj
ET
Q
q
BT
/F3 1 Tf
9 0 0 9 311.811 506.3016 Tm
0 Tr
0 0 0 1 k
0 Tc
0.05 Tw
(Study Design:)Tj
ET
Q
q
BT
/F2 1 Tf
9 0 0 9 367.2062 506.3016 Tm
0 Tr
0 0 0 1 k
0 Tc
0.05 Tw
(80 patients in the reproductive period with the)Tj
-6.15502 -1.11111 TD
0.098 Tw
(desire of tubal sterilization were included in the prospective,)Tj
T*
0.084 Tw
(randomized study. The patients were divided into two groups)Tj
T*
0.005 Tc
0.12 Tw
(by simple randomization as tubal sterilization through elec-)Tj
T*
0 Tc
0.064 Tw
(trocoagulation group and the application of mechanical clips)Tj
T*
0.084 Tw
(group. Day three serum basal FSH, LH, estradiol, inhibin-B,)Tj
T*
0.103 Tw
(antimullerian hormone, total basal ovarian volume measure-)Tj
T*
0.076 Tw
(ments and anthral follicle counts of all patients in the preop-)Tj
T*
0.007 Tc
0.118 Tw
(erative and 10th postoperative months were compared both)Tj
T*
0 Tc
0 Tw
(within and between the two groups.)Tj
ET
Q
q
BT
/F3 1 Tf
9 0 0 9 311.811 396.3016 Tm
0 Tr
0 0 0 1 k
0.014 Tc
0 Tw
(Results:)Tj
ET
Q
q
BT
/F2 1 Tf
9 0 0 9 346.1955 396.3016 Tm
0 Tr
0 0 0 1 k
0.014 Tc
(A)Tj
0.99989 0 Td
0.111 Tw
(significant difference between the postoperative)Tj
-4.82038 -1.11111 TD
0.004 Tc
0.121 Tw
(10th month total basal ovarian volumes and anthral follicle)Tj
0 -1.11112 TD
0.029 Tc
0.096 Tw
(counts were detected between the electrocoagulation and)Tj
0 -1.11111 TD
0 Tc
0 Tw
(mechanical clips application groups.)Tj
ET
Q
q
BT
/F3 1 Tf
9 0 0 9 311.811 346.3016 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Conclusion:)Tj
ET
Q
q
BT
/F2 1 Tf
9 0 0 9 360.3755 346.3016 Tm
0 Tr
0 0 0 1 k
0 Tc
0.09 Tw
(Laparoscopic tubal sterilization by electrocoag-)Tj
-5.39605 -1.11111 TD
0.062 Tw
(ulation is very likely to have an adverse effect on the ovarian)Tj
T*
0 Tw
(reserve in the postoperative period.)Tj
ET
Q
q
BT
/F3 1 Tf
9 0 0 9 311.811 306.3017 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Key words: )Tj
ET
Q
q
BT
/F2 1 Tf
9 0 0 9 355.3015 306.3017 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Tubal sterilization, ovarian reserve)Tj
ET
0 J 0 j 10 M []0 d 1 w
0 0 0 1 K
56.693 153.26 m
538.583 153.26 l
S
56.693 291.331 m
538.583 291.331 l
S
0 0 0 0 k
56.693 789.197 136.063 10.173 re
f
Q
q
BT
/F2 1 Tf
8 0 0 8 57.6929 792.4114 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(G\232ztepe T\335p Dergisi 23(4):126-132, 2008)Tj
ET
0 0 0 0 k
56.693 92.544 17.008 12.338 re
f
Q
q
BT
/F0 1 Tf
10 0 0 10 57.6929 96.4236 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(126)Tj
ET
0 0 0 0 k
470.551 788.1971 68.027 11.1729 re
f
Q
q
BT
/F0 1 Tf
9 0 0 9 471.551 791.6577 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(ISSN 1300-526X)Tj
ET
Q
endstream
endobj
4 0 obj
<<
/Length 10698
>>
stream
/GS0 gs
q
0 0.89 595 841 re
W n
1 g
0 841.89 0 0 re
f
Q
/GS1 gs
q
0 0 0 0 k
56.693 119.055 481.89 637.796 re
f
Q
q
BT
/F1 1 Tf
11 0 0 11 57.6929 747.2382 Tm
0 Tr
0 0 0 1 k
0.006 Tc
0.119 Tw
[(2003'te elde edilen veri)-1(lere g\232re \237lkemiz)-1(de tubal)]TJ
0 -1.27273 TD
-0.0002 Tc
(s)Tj
0.3888 -0.00001 TD
0 Tc
0 Tw
[(teri)-1(lizasyon insidan)-1(s\335 %)-250(5.7\325)1(dir )]TJ
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 202.1753 735.8781 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
((4))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 211.4996 733.2381 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
-13.98243 -2.54545 TD
0.005 Tc
0.12 Tw
[(Bu \215al\335sma, tubal ste)-1(rilizasyon i\337)-1(lemleri)-1(nin ovar-)]TJ
0 -1.27273 TD
0.004 Tc
0.121 Tw
[(yen kan ak\335m\335n\335 et)-1(kileyerek over rezer)-1(vini olum-)]TJ
0 -1.27272 TD
[(suz etkile)-1(yebilece)-1(\333i hipotezine daya)-1(n\335larak yap\335l-)]TJ
0 -1.27273 TD
[(m\335\337t\335r. Tubal ster)1(il)1(i)1(zasyon s\335)-1(r)1(a)1(s\335nda tubo-ovaryen)]TJ
T*
0 Tc
0.092 Tw
[(anastomozla)-1(r\335n bozulmas\335 nede)-1(niyle overlerin kan)]TJ
T*
0.056 Tw
[(ak\335m\335n\335n bo)-1(zulmas\335, hem elektrokoagulas)-1(yon y\232n-)]TJ
0 -1.27272 TD
0.019 Tc
0.106 Tw
[(temiyle hem de me)-1(kanik klips y\232ntemiyle tubal)]TJ
0 -1.27273 TD
0 Tc
0.029 Tw
[(steri)-1(lizasyonda kar\337\335)-1(la\337\335labi)-1(lecek bir durumdur. Bu)]TJ
0 -1.27272 TD
0.004 Tc
0.121 Tw
[<8D616CDDDF>-1(mada bu iki y\232ntem ile tubal steri)-1(lizasyonun)]TJ
0 -1.27273 TD
0 Tc
0 Tw
[(ovaryen rezer)-1(vine etkisini ara\337t\335r)-1(may\335 ama\215lad\335k.)]TJ
ET
Q
q
BT
/F0 1 Tf
11 0 0 11 57.6929 551.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(MATERYAL ve METOD)Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 57.6929 523.2381 Tm
0 Tr
0 0 0 1 k
0.024 Tc
0.101 Tw
[(Bu prospektif randomi)-1(ze \215al\335\337ma, S.B. \334stanbul)]TJ
0 -1.27271 TD
0.036 Tc
0.089 Tw
[(G\232zt)1(e)1(pe E\333i)-1(tim ve Ara\337t\335rma Hast)1(a)1(ne)-1(si Kad\335n)]TJ
0 -1.27273 TD
0 Tc
0.084 Tw
[(Hastal\335k)-1(lar\335 ve Do\333um Klini\333i\325nde, Ocak 2007 ve)]TJ
T*
0.016 Tw
[(Hazi)-1(ran 2008 tarihleri aras\335nda ger)-1(\215ekle\337tiril)-1(mi\337tir.)]TJ
T*
0.116 Tw
[(\202al\335\337ma S.B. \334stan)-1(bul G\232ztepe E\333itim ve Ara\337t\335r)-1(-)]TJ
T*
0.015 Tc
0.11 Tw
[(ma Hastane)-1(si Etik kurulu tara)-1(f\335ndan onaylanm\335\337)]TJ
T*
0 Tc
0.01 Tw
[(olup, \215al\335\337ma)-1(ya kat\335lan t\237m hastalar onay)-1(lar\335 al\335na-)]TJ
0 -1.27272 TD
0 Tw
(rak ara\337)Tj
3.13599 0 TD
[(t\335rma)-1(ya dahil edilmi\337lerdir. )]TJ
-3.13599 -2.54546 TD
0.041 Tc
(Pe)Tj
1.08188 0.00001 TD
(ri)Tj
0.69272 0.00001 TD
0.0407 Tc
(me)Tj
1.3038 0 TD
0.041 Tc
(na)Tj
1.02597 0 TD
(po)Tj
1.08212 0.00001 TD
0.084 Tw
(zal semp)Tj
3.93856 0 TD
0 Tw
(tom)Tj
1.67885 0 TD
0.084 Tw
(lar\335 var olan, anormal)Tj
-10.80389 -1.27274 TD
0 Tc
0.07 Tw
(body-mass in)Tj
5.42995 0.00001 TD
0 Tw
(dek)Tj
1.44384 0 TD
(si)Tj
0.66674 0 TD
0.07 Tw
(ne sa)Tj
2.09645 0.00001 TD
[(hip, endokrinolo)-1(jik patolo-)]TJ
-9.63698 -1.27274 TD
0.007 Tw
[(jile)-1(ri saptanan, ailesin)-1(de prematur ovaryen yetmez-)]TJ
0 -1.27272 TD
0.002 Tc
0.123 Tw
(lik hi)Tj
2.21918 0 TD
[(kayesi mevcut, 25 mili)-1(metreden b\237y\237k over)]TJ
-2.21918 -1.27273 TD
0.013 Tc
0.112 Tw
[(kisti izle)-1(nen ve bir sene \232ncesinde veya \215al\335\337ma)]TJ
0 -1.27272 TD
0 Tc
0 Tw
(bo)Tj
1 0.00001 TD
(yun)Tj
1.5 0.00001 TD
0.113 Tw
(ca pel)Tj
2.47213 0.00001 TD
(vik cer)Tj
2.86105 0.00001 TD
0 Tw
(ra)Tj
0.77661 0.00001 TD
0.113 Tw
(hi ge)Tj
2.08443 0.00001 TD
[(\215iren hasta)-1(lar \215al\335\337maya)]TJ
-10.69421 -1.27276 TD
0.062 Tw
[(dahil edilme)-1(mi\337tir. \202al\335\337maya se)-1(\215ilen t\237m hastala)-1(-)]TJ
0 -1.27272 TD
0.122 Tw
(r\335n over re)Tj
4.407 0.00001 TD
0 Tw
(zerv)Tj
1.72046 0.00001 TD
(le)Tj
0.72167 0.00001 TD
0.122 Tw
[(ri normal s\335n\335rlar)-1(da idi. Menstru-)]TJ
-6.84914 -1.27274 TD
0 Tw
(las)Tj
1.1106 0.00001 TD
0.001 Tw
[(yon sikluslar\335 d\237)-1(zenliydi, kendi \232zge\215mi\337le)-1(rinde)]TJ
-1.1106 -1.27274 TD
0.001 Tc
0.124 Tw
[(ve aile hikaye)-1(lerinde prematur ovaryen yet)-1(mezlik)]TJ
0 -1.27272 TD
0 Tc
0.095 Tw
[(y\232n\237nden herhangi bir risk ta\337\335)-1(m\335yorlard\335. Ya\337la)-1<72DD>]TJ
0 -1.27273 TD
0.031 Tw
[(35 ile 40 aras\335nda olan ve g\232n\237ll\237 olarak tu)-1(bal ste-)]TJ
T*
0.018 Tc
0.107 Tw
[(r)1(i)1(l)1(iz)1(a)1(s)1(yon ist)1(e)1(mi\337 olan 80 hasta \215a)-1(l)1
11(m)1(a)1(ya dahil)]TJ
T*
0 Tc
0.04 Tw
[(edildi. Hasta)-1(lar elektrokoagulasyon y\232nte)-1(mi ile tu-)]TJ
T*
0.007 Tc
0.118 Tw
(bal ste)Tj
2.74779 0.00001 TD
0.006 Tc
0 Tw
(ri)Tj
0.6241 0.00001 TD
(li)Tj
0.56917 0.00001 TD
0.007 Tc
(zas)Tj
1.29687 0.00001 TD
0.118 Tw
[(yon yap\335lanlar (40 tane) ve me)-1(kanik)]TJ
-5.23794 -1.27275 TD
0 Tc
0.07 Tw
[(klips y\232ntemi ile tubal ste)-1(rilizas)-1(yon yap\335lanlar \(40)]TJ
0 -1.27273 TD
0 Tw
(ta)Tj
0.72168 0.00001 TD
0.034 Tw
[(ne\) olmak \237zere basit randomi)-1(ze \232rnekleme y\232n-)]TJ
-0.72168 -1.27273 TD
0 Tw
[(temiyle iki gru)-1(ba ayr\335ld\335. )]TJ
0 -2.54546 TD
0.093 Tw
[(Preopera)-1(tif d\232nemde adetin 3. g\237n\237nde serum ba-)]TJ
23.10165 56 TD
0.016 Tc
0.109 Tw
[(zal FSH, LH, estradiol, in)-1(hibin B, antimulle)-1(rian)]TJ
0 -1.27273 TD
0.001 Tc
(h)Tj
0.50098 -0.00001 TD
0.124 Tw
[(ormon seviye)-1(leri antekubital ven)-1(lerden elde edi-)]TJ
-0.50098 -1.27272 TD
0 Tc
0 Tw
[(len ven\232z kanda \232l\215\237ld\237. Ayn\335 g\237n, transva)-1(jinal ul-)]TJ
0 -1.27273 TD
0.002 Tc
0.123 Tw
[(trason ile total bazal over hacmi ve an)-1(tral folikul)]TJ
T*
0 Tc
0.106 Tw
[(say\335mla)-1(r\335 elde edildi. T\237m ultrasonogra)-1(fik \232l\215\237m-)]TJ
0 -1.27272 TD
0.04 Tw
[(ler, ayn\335 uygulay\335)-1(c\335 taraf\335ndan Logiq-200Pro ul)-1(tra-)]TJ
0 -1.27273 TD
0.094 Tw
(sonun 5.0 MHz probu ile yap\335ld\335. Over hacmi her)Tj
T*
0.045 Tw
[(iki overin dikey (D1), ante)-1(ro-posterior (D2) ve ya)-1(-)]TJ
T*
0.009 Tc
0.116 Tw
[(tay (D3) \215aplar\335)-1(n\335n \232l\215\237lmesi ve prola)-1(te elipsoid)]TJ
0 -1.27272 TD
0 Tc
0.066 Tw
[(form\237l\237)-1(n\237n \(Volume=D1 x D2 x D3 x )]TJ
ET
Q
q
BT
/F4 1 Tf
11 0 0 11 490.1934 621.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
(p)Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 496.2305 621.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
0.066 Tw
(/6\) uygu-)Tj
-16.76541 -1.27273 TD
0.056 Tw
[(lanmas\335y)-1(la hesapland\335. Antral foli)-1(kul say\335s\335 her iki)]TJ
0 -1.27272 TD
0.012 Tw
[(overde bulunan 2-10 mili)-1(metre boyutlu foli)-1(kullerin)]TJ
0 -1.27273 TD
0 Tw
[(say\335lma)-1(s\335yla elde edildi. )]TJ
0 -2.54545 TD
0.09 Tw
[(Gebelik olas\335)-1<6CDDDBDD6EDD206F727461>-1(dan kald\335rmak i\215in hastalar)]TJ
0 -1.27273 TD
0.036 Tw
[(menstrulas)-1(yon sikluslar\335n\335n fo)-1(likuler faz\335nda opere)]TJ
T*
0.005 Tc
0.119 Tw
[(edildi. T\237m laparos)-1(k)-1(o)-1(pik tubal sterilizas)-1(y)-1(o)-1(n)-1( )-1(o)-1(p)-1(e)-1(-)]TJ
0 -1.27271 TD
0.01 Tc
0.114 Tw
[(rasy)-1(o)-1(n)-1(la)-1(r\335 genel anestezi alt\335n)-1(da yap\335ld\335. Verress)]TJ
0 -1.27273 TD
0.017 Tc
0.108 Tw
[(i\333nesi hasta n\232t)-1(ral pozisyonda iken yerle\337t)1(i)1(ril)-1(di.)]TJ
T*
0.049 Tc
0.076 Tw
[(Peri)-1(tona giri\337 teyit edildikten sonra, ba)-1(t\335n 14)]TJ
T*
0.022 Tc
0.103 Tw
[(mmHg bas\335nca kadar karbondi)-1(oksit ile \337i\337irildi.)]TJ
T*
0.014 Tc
0.111 Tw
[(Trokarlar yer)-1(le\337tirildik)-1(ten sonra hasta trendelen-)]TJ
T*
0 Tc
0.056 Tw
[(burg pozisyonuna geti)-1(rildi. Eksplorasyon s\335ra)-1(s\335nda)]TJ
0 -1.27272 TD
0 Tw
(bi)Tj
0.77783 0 TD
0.001 Tw
[(late)-1(ral tubalar\335n genel g\232r\237n)-1(t\237s\237ne ve mobilite)-1(le-)]TJ
-0.77783 -1.27273 TD
0.003 Tc
0.122 Tw
[(r)1(i)1(ne ba)-1(k)11(l)1(d\335. Elekt)1(r)1(o)1(koagul)1(a)1(s)1(yon y\232nt)1(emi uygul)1(a)1(-)]TJ
T*
0 Tc
0.118 Tw
(nan has)Tj
3.1442 0.00001 TD
(ta gru)Tj
2.42203 0.00001 TD
0 Tw
(bun)Tj
1.5 0 TD
0.118 Tw
(da, tu)Tj
2.33926 0 TD
0 Tw
(ba)Tj
0.94385 0.00001 TD
(la)Tj
0.72168 0 TD
0.118 Tw
(r\335n tu)Tj
2.25601 0 TD
[(bo-uterin bile\337ke)-1(-)]TJ
-13.32703 -1.27274 TD
0.048 Tw
(ye 3 san)Tj
3.37295 0.00001 TD
0 Tw
(ti)Tj
0.55566 0 TD
(met)Tj
1.49952 0 TD
0.048 Tw
(re uzak)Tj
2.96247 0.00001 TD
[(l\335ktaki k\335s)-1(m\335na 30-40 W kesi-)]TJ
-8.39061 -1.27274 TD
0.019 Tw
[(ci dalga formlu bipolar koter uy)-1(guland\335. Koterizas)-1(-)]TJ
0 -1.27272 TD
0 Tw
(yo)Tj
1 0 TD
0.051 Tw
[(nu takiben, u\215la)-1(r\335n birbirinden tama)-1(men ayr\335ld\335-)]TJ
-1 -1.27273 TD
0.125 Tw
[(\333\335ndan emin olundu\333unda tubalar ke)-1(sildi. Gerekli)]TJ
0 -1.27272 TD
0 Tw
<679A>Tj
1 0.00001 TD
<729F>Tj
0.83276 0.00001 TD
0.123 Tw
(len du)Tj
2.59508 0.00001 TD
0 Tw
(rum)Tj
1.61059 0.00001 TD
(lar)Tj
1.05445 0.00001 TD
0.123 Tw
(da ke)Tj
2.26109 0.00001 TD
[(sik u\215lara kote)-1(rizasyon uy-)]TJ
-9.35397 -1.27276 TD
0.073 Tw
[(guland\335. Mekanik klipsle)-1(rin kullan\335ld\335)-1(\333\335 hasta gru-)]TJ
0 -1.27272 TD
0.016 Tc
0 Tw
(bun)Tj
1.54694 0.00001 TD
0.109 Tw
(da tu)Tj
2.15927 0.00001 TD
0.015 Tc
0 Tw
(ba)Tj
0.97514 0.00001 TD
0.016 Tc
0.109 Tw
[(l)1(a)1(r\335n uter)1(usa 3 sant)1(i)1(m)1(e)1(t)1(re uzak)-1(l)11(k)1(t)1(a)1(k)1(i)]TJ
-4.68136 -1.27274 TD
0 Tc
0 Tw
(ser)Tj
1.16553 0.00001 TD
0.029 Tw
[(best k\335sm\335na, tu)-1(b)1(a)-1(n\335n tamam\335n\335 i\215e)-1(recek \337ekilde)]TJ
-1.16553 -1.27274 TD
0.076 Tw
[(iki tane yan yana klips uyguland\335. Tuba)-1(lar\335n ba\337a-)]TJ
0 -1.27272 TD
0.098 Tw
[(r\335yla kapat\335l)-1(mas\335ndan sonra, abdomi)-1(nal eksploras-)]TJ
0 -1.27273 TD
0 Tw
[(yonu takiben operas)-1(yonu sonland\335r\335ld\335. )]TJ
0 -2.54545 TD
0.036 Tw
[(Postopera)-1(tif d\232nemde enfeksi)-1(yon bulgular\335 saptan-)]TJ
0 -1.27273 TD
0 Tw
(ma)Tj
1.22168 0.00001 TD
0.099 Tw
(yan has)Tj
3.12519 0.00001 TD
0 Tw
(ta)Tj
0.72168 0.00001 TD
(la)Tj
0.72168 0.00001 TD
0.099 Tw
[(ra antibi)-1(yoterapi uygulan)-1(mad\335. Has-)]TJ
-5.79023 -1.27275 TD
0.01 Tc
0.115 Tw
[(talar posto)-1(peratif birinci g\237n)-1(de taburcu edildiler.)]TJ
0 -1.27273 TD
0.001 Tc
0.124 Tw
(T\237m has)Tj
3.6012 0.00001 TD
[(t)1(a)1(lar posto)-1(per)1(a)1(tif 10. ayda kontro)-1<6C65208D61DBDD2D>]TJ
-3.6012 -1.27273 TD
0 Tc
0.07 Tw
[(r\335ld\335. 3. g\237n serum bazal FSH, LH, es)-1(tradiol, inhi-)]TJ
T*
0.121 Tw
[(bin B, antimul)-1(lerian hormon d\237zey)-1(leri \232l\215\237ld\237 ve)]TJ
T*
0.117 Tw
[(transvaji)-1(nal ultrason ile total bazal over hacim)-1(leri)]TJ
ET
0 0 0 0 k
56.693 789.197 481.89 10.173 re
f
Q
q
BT
/F2 1 Tf
8 0 0 8 57.6929 792.4114 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(N. S\237er ve ark., Tubal sterilizasyonda elektrokoag\237lasyon ve mekanik klips y\232ntemlerinin over rezervine etkilerinin kar\337\335la\337t\335r\335lmas\335)Tj
ET
0 0 0 0 k
521.575 92.544 17.0079 12.338 re
f
Q
q
BT
/F0 1 Tf
10 0 0 10 522.5747 96.4239 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(127)Tj
ET
Q
endstream
endobj
5 0 obj
<<
/Length 8975
>>
stream
/GS0 gs
q
0 0.89 595 841 re
W n
1 g
0 841.89 0 0 re
f
Q
/GS1 gs
q
0 0 0 0 k
56.693 420.347 481.89 336.504 re
f
Q
q
BT
/F1 1 Tf
11 0 0 11 57.6929 747.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
[(ve antral foli)-1(kul say\335mlar\335 de\333erlen)-1(dirildi. )]TJ
ET
Q
q
BT
/F0 1 Tf
11 0 0 11 57.6929 719.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(\334statistiksel de\333erlendirme)Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 57.6929 691.2381 Tm
0 Tr
0 0 0 1 k
0.05 Tc
0.075 Tw
[(\202al\335\337ma ve)-1(r)1(i)1(l)1(e)1(r)1(inin anal)1(i)1(zinde Windows 15,0)]TJ
0 -1.27272 TD
0.033 Tc
0.092 Tw
[(SPSS \(Statisti)-1(cal Package for Social Sci)-1(ences\))]TJ
0 -1.27273 TD
0.005 Tc
0.12 Tw
[(progr)1(a)1(m\335 kul)-1(l)1(a)1(n)11(l)1(d\335. Ver)1(il)1(e)1(rin de\333)1(e)1(r)1(l)1(e)1(n)1(d)1(ir)1(i)1(l)1(m)1(e)1(sin-)]TJ
0.0387 Tc
(de)'
1.39635 0 Td
0.039 Tc
0.086 Tw
[(tan\335mla)-1(y\335c\335 istatistik)-1(sel metotlar \(orta)-1(lama,)]TJ
-1.39635 -1.27273 TD
0.006 Tc
0.119 Tw
[(standart devias)-1(yon\) kullan\335la)-1(rak, de\333i\337kenler pai-)]TJ
0 -1.27272 TD
0 Tc
0.01 Tw
[(red veya unpaired t-test ile kar\337\335)-1<6C61DF74DD72DD6C>-1(d\335. \334statistik-)]TJ
0 -1.27273 TD
0.037 Tw
[(sel anlaml\335)-1(l\335k p <0.05, ve % 95\325lik g\237ven aral\335\333\335n-)]TJ
0 -1.27272 TD
0 Tw
(da kabul edildi. )Tj
ET
Q
q
BT
/F0 1 Tf
11 0 0 11 57.6929 565.2381 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(BULGULAR)Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 57.6929 537.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
0.049 Tw
[(Elektrokoagulas)-1(yon y\232ntemi ile tubal steri)-1(lizasyon)]TJ
0 -1.27273 TD
0.022 Tc
0.103 Tw
[(uygulanan hasta)-1(lar\335n ya\337 ortala)-1(mas\335 37.14\2611.62)]TJ
0 -1.27271 TD
0 Tc
0.093 Tw
[(iken, mekanik klips ile tubal steri)-1(lizasyon uygula)-1(-)]TJ
0 -1.27273 TD
0.011 Tc
0.114 Tw
[(nan hastala)-1(r\335n ya\337 ortalama)-1(s\335 37.24\2611.68 idi. \334ki)]TJ
T*
0 Tc
0.117 Tw
[<8D616CDDDF>-1(ma grubu aras\335nda ortala)-1(ma ya\337 a\215\335s\335ndan is-)]TJ
T*
0.068 Tc
0.057 Tw
[(tatis)-1(tiksel olarak anlaml\335 bir fark izlen)-1(medi)]TJ
T*
0 Tc
0 Tw
((p<0.05). )Tj
0 -2.54545 TD
0.084 Tw
(Her iki gru)Tj
4.55549 0 TD
[(bun preopera)-1(tif 3. g\237n over rezervi be-)]TJ
18.54615 29.27272 TD
0.02 Tw
[(lirte\215)-1(leri tablo)-270(1\325de \232zetlenmi\337tir. \334ki grup aras\335n)-1(da)]TJ
0 -1.27273 TD
-0.0002 Tc
(p)Tj
0.4998 -0.00001 TD
0 Tc
0.108 Tw
[(reopera)-1(tif ortalama to)-1(tal bazal ovaryen hacim ve)]TJ
-0.4998 -1.27272 TD
0.006 Tc
0.119 Tw
[(antral foli)-1(kul say\335m\335 bak\335m\335n)-1(dan istatistiksel ola)-1(-)]TJ
0 -1.27273 TD
0 Tc
0.064 Tw
[(rak anlaml\335 bir fark izlen)-1(memi\337tir \(p<0.05\) \(Tablo)]TJ
T*
0 Tw
(1\).)Tj
0 -2.54545 TD
0.049 Tw
[(Elektrokoagulas)-1(yon y\232ntemi ile tubal steri)-1(lizasyon)]TJ
0 -1.27273 TD
0.057 Tw
[(uygulanan hasta grubunda pre)-1(operatif d\232nemde ve)]TJ
T*
0.047 Tw
[(postopera)-1(tif 10. ayda elde edilen ortala)-1(ma ovaryen)]TJ
0 -1.27272 TD
0.009 Tc
0.116 Tw
[(rezerv belir)-1(te\215leri tablo)-376(2\325de \232zetlenmi\337tir. Elek-)]TJ
0 -1.27273 TD
0 Tc
0.089 Tw
[(trokoagulasyon y\232nt)-1(emi ile tubal sterili)-1(zasyon uy-)]TJ
0 -1.27272 TD
0.073 Tw
[(gulanan grupta, trans)-1(v)1(a)-1(jinal ultrasonogra)-1(fi ile elde)]TJ
0 -1.27273 TD
0.098 Tw
[(edilen total bazal ovar)-1(yen hacimler a\215\335s\335ndan pre-)]TJ
T*
0.015 Tc
0.11 Tw
[(operatif d\232)-1(nem (11.62\2612.49) ve postoperatif 10.)]TJ
0 -1.27272 TD
0 Tc
0.088 Tw
[(aylar (10.80\2612.10) aras\335nda ista)-1(tistiksel olarak an-)]TJ
0 -1.27273 TD
0.115 Tw
[(laml\335 bir fark izlen)-1(mi\337tir (p<0.01). Ayn\335 zamanda)]TJ
T*
0.005 Tc
0.12 Tw
[(orta)-1(lama antral foli)-1(kul say\335mlar\335 aras\335n)-1(da da pre-)]TJ
0 -1.27271 TD
0.015 Tc
0.11 Tw
[(operatif d\232)-1(nem (12.15\2612.89) ve postoperatif 10.)]TJ
0 -1.27273 TD
0.019 Tc
0.106 Tw
[(aylarda (10.52\2612.34) ista)-1(tistiksel olarak anlam)-1<6CDD>]TJ
T*
0 Tc
0 Tw
[(bir fark izlenmi\337tir \(p<0.01\) \(Tab)-1(lo)-250(2\).)]TJ
0 -2.54545 TD
0.003 Tc
0.122 Tw
[(M)1(e)1(kanik klips y\232nt)1(emi ile tubal ster)1(il)1(i)1(z)1(a)1(s)1(yon uy-)]TJ
0 -1.27273 TD
0.002 Tc
0.123 Tw
[(gulanan grupta pre)-1(operatif d\232nem ve postope)-1(ratif)]TJ
0 -1.27272 TD
0 Tc
0.084 Tw
(10. ay)Tj
2.52829 0 TD
[(da elde edilen orta)-1(lama ovaryen rezerv g\232s-)]TJ
ET
0 0 0 0 k
56.693 390.5171 481.889 13.542 re
f
Q
q
BT
/F0 1 Tf
8 0 0 8 57.6929 397.0926 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Tablo 1. Preoperatif d\232nem ovaryen rezerv belirte\215lerinin her iki grup aras\335nda kar\337\335la\337t\335r\335lmas\335.)Tj
ET
0 0 0 0 k
56.693 288.339 141.732 97.512 re
f
BT
/F0 1 Tf
8 0 0 8 57.6929 378.5872 Tm
0 0 0 1 k
(Preoperatif d\232nem)Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 57.6929 351.5872 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Bazal folikuler stimulan hormon (mIU/ml))Tj
0 -1.125 TD
(Bazal luteinizan hormon (mIU/ml))Tj
T*
(Bazal ekstradiol (pg/ml))Tj
T*
(Bazal inhibin-B (ng/ml))Tj
T*
(Bazal antimullerian hormon (ng/ml))Tj
T*
(Total bazal over hacmi \(cm)Tj
ET
Q
q
BT
/F1 1 Tf
6 0 0 6 145.646 308.5672 Tm
0 Tr
0 0 0 1 k
0 Tc
(3)Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 148.646 306.5871 Tm
0 Tr
0 0 0 1 k
0 Tc
(\))Tj
-11.36914 -1.125 TD
0 Tw
(Antral folikul say\335m\335)Tj
ET
0 J 0 j 10 M []0 d 1 w
0 0 0 1 K
56.693 390.318 m
538.582 390.318 l
S
0 0 0 0 k
263.622 288.324 75.779 97.526 re
f
Q
q
BT
/F0 1 Tf
8 0 0 8 267.2891 378.8832 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Elektrokoagulasyon )Tj
2.11902 -1.125 TD
((Ort.\261SD))Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 285.2559 351.8832 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(5.88\2612.01)Tj
0 -1.125 TD
(5.14\2612.76)Tj
-0.5 -1.125 TD
(48.92\26122.88)Tj
T*
(80.31\26139.68)Tj
0.5 -1.125 TD
(2.63\2610.95)Tj
-0.25 -1.125 TD
(11.62\2612.49)Tj
T*
(12.15\2612.89 )Tj
ET
0 0 0 0 k
390.173 288.338 66.205 97.512 re
f
Q
q
BT
/F0 1 Tf
8 0 0 8 398.717 378.8832 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Mekanik klips)Tj
0.911 -1.125 TD
((Ort.\261SD))Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 407.0197 351.8832 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(6.72\2612.56)Tj
0 -1.125 TD
(6.12\2612.16)Tj
-0.5 -1.125 TD
(52.94\26125.69)Tj
T*
(87.42\26139.78)Tj
0.5 -1.125 TD
(2.68\2610.90)Tj
-0.25 -1.125 TD
(12.01\2612.90)Tj
T*
(12.19\2612.94 )Tj
ET
0 J 0 j 10 M []0 d 1 w
0 0 0 1 K
56.693 364.415 m
538.582 364.415 l
S
0 0 0 0 k
521.967 288.338 16.616 97.512 re
f
Q
q
BT
/F0 1 Tf
8 0 0 8 528.0513 378.5865 Tm
0 Tr
0 0 0 1 k
0 Tc
(p)Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 523.275 351.5865 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(0.09)Tj
0 -1.125 TD
(0.07)Tj
T*
(0.44)Tj
T*
(0.40)Tj
T*
(0.80)Tj
T*
(0.50)Tj
T*
(0.95)Tj
ET
0 J 0 j 10 M []0 d 1 w
0 0 0 1 K
56.693 288.2721 m
538.582 288.2721 l
S
0 0 0 0 k
56.693 236.71 481.889 13.542 re
f
Q
q
BT
/F0 1 Tf
8 0 0 8 57.6929 243.2851 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Tablo 2. Elektrokoagulasyon grubu preoperatif d\232nem ve postoperatif 10. ay ovaryen rezerv belirte\215 de\333erleri kar\337\335la\337t\335r\335lmas\335.)Tj
ET
0 0 0 0 k
56.693 141.3481 141.732 90.695 re
f
Q
q
BT
/F1 1 Tf
8 0 0 8 57.6929 206.7796 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Bazal folikuler stimulan hormon (mIU/ml))Tj
0 -1.125 TD
(Bazal luteinizan hormon (mIU/ml))Tj
T*
(Bazal ekstradiol (pg/ml))Tj
T*
(Bazal inhibin-B (ng/ml))Tj
T*
(Bazal antimullerian hormon (ng/ml))Tj
T*
(Total bazal over hacmi \(cm)Tj
ET
Q
q
BT
/F1 1 Tf
6 0 0 6 145.646 163.7596 Tm
0 Tr
0 0 0 1 k
0 Tc
(3)Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 148.646 161.7796 Tm
0 Tr
0 0 0 1 k
0 Tc
(\))Tj
-11.36914 -1.125 TD
0 Tw
(Antral folikul say\335m\335)Tj
ET
0 J 0 j 10 M []0 d 1 w
0 0 0 1 K
56.693 236.5101 m
538.582 236.5101 l
S
0 0 0 0 k
279.622 141.334 75.779 90.709 re
f
Q
q
BT
/F0 1 Tf
8 0 0 8 282.7578 224.7789 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Preoperatif de\333erler )Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 301.2559 206.7789 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(5.88\2612.01)Tj
0 -1.125 TD
(5.14\2612.76)Tj
-0.5 -1.125 TD
(48.92\26122.88)Tj
T*
(80.31\26139.68)Tj
0.5 -1.125 TD
(2.63\2610.95)Tj
-0.5 -1.125 TD
(11.62\2612.49*)Tj
T*
(12.15\2612.89*)Tj
ET
0 0 0 0 k
431.316 141.347 107.267 90.696 re
f
Q
q
BT
/F0 1 Tf
8 0 0 8 436.7482 224.7789 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Postoperatif 10. ay de\333erleri)Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 468.6935 206.7789 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(6.13\2612.90)Tj
0 -1.125 TD
(5.35\2612.01)Tj
-0.5 -1.125 TD
(50.26\26127.68)Tj
T*
(78.41\26132.88)Tj
0.5 -1.125 TD
(2.42\2610.25)Tj
-0.5 -1.125 TD
(10.80\2612.10*)Tj
T*
(10.52\2612.34*)Tj
ET
0 J 0 j 10 M []0 d 1 w
0 0 0 1 K
56.693 218.607 m
538.582 218.607 l
S
0 0 0 0 k
56.693 273.667 481.89 11.226 re
f
Q
q
BT
/F2 1 Tf
8 0 0 8 57.6929 277.9344 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Unpaired t-testi uygulanm\335\337t\335r.)Tj
ET
0 0 0 0 k
56.693 119.055 481.89 19.159 re
f
BT
/F2 1 Tf
8 0 0 8 57.6929 131.2549 Tm
0 0 0 1 k
(Paired t-testi uygulanm\335\337t\335r.)Tj
0 -1.125 TD
(*p<0.01)Tj
ET
0 J 0 j 10 M []0 d 1 w
0 0 0 1 K
56.693 141.464 m
538.582 141.464 l
S
0 0 0 0 k
402.52 789.197 136.063 10.173 re
f
BT
/F2 1 Tf
8 0 0 8 403.5198 792.4114 Tm
0 0 0 1 k
(G\232ztepe T\335p Dergisi 23(4):126-132, 2008)Tj
ET
0 0 0 0 k
56.693 92.544 17.008 12.338 re
f
Q
q
BT
/F0 1 Tf
10 0 0 10 57.6929 96.4236 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(128)Tj
ET
Q
endstream
endobj
6 0 obj
<<
/Length 11223
>>
stream
/GS0 gs
q
0 0.89 595 841 re
W n
1 g
0 841.89 0 0 re
f
Q
/GS1 gs
q
0 0 0 0 k
56.693 119.055 481.89 339.095 re
f
Q
q
BT
/F1 1 Tf
11 0 0 11 57.6929 448.5374 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(ter)Tj
1.05445 0.00001 TD
0.036 Tw
[(geleri tab)-1(lo)-285(3'de \232zetlen)-1(mi\337tir. Bu hasta grubun-)]TJ
-1.05445 -1.27273 TD
0.091 Tw
[(da preopera)-1(tif d\232nemde menstrulasyon siklu)-1(sunun)]TJ
0 -1.27272 TD
0.007 Tc
0.118 Tw
(3. g\237)Tj
2.15466 0 TD
(n\237 de)Tj
2.34851 0 TD
0 Tw
(\333er)Tj
1.29886 0.00001 TD
(len)Tj
1.24393 0 TD
(di)Tj
0.79266 0 TD
(ri)Tj
0.62543 0.00001 TD
0.118 Tw
(len or)Tj
2.46652 0 TD
[(tala)-1(ma total bazal over)]TJ
-10.93057 -1.27275 TD
0 Tc
0.036 Tw
(hacmi 12.01\2612.90 cm)Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 154.4977 409.1775 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 161.6405 406.5374 Tm
0 Tr
0 0 0 1 k
0 Tc
0.036 Tw
[(iken, postopera)-1(tif 10. ayda-)]TJ
-9.44978 -1.27273 TD
0.078 Tw
(ki de)Tj
2.04986 0.00001 TD
(\333er 11.82\2612.21cm)Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 161.5363 395.1775 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 169.1463 392.5374 Tm
0 Tr
0 0 0 1 k
0 Tc
0.078 Tw
(idi. Bu iki de)Tj
5.45673 0.00001 TD
(\333er aras\335nda)Tj
-15.58885 -1.27273 TD
0.048 Tc
0.076 Tw
[(ista)-1(tistiksel olarak anlaml\335 bir fark iz)-1(lenmedi)]TJ
T*
0.03 Tc
0.095 Tw
[((p>0.05). Ortala)-1(ma antral folikul say\335m\335n)-1(da da)]TJ
0 -1.27272 TD
0.023 Tc
0 Tw
(pre)Tj
1.34747 0.00001 TD
0.024 Tc
(ope)Tj
1.51471 0.00001 TD
0.023 Tc
(ra)Tj
0.82385 0 TD
0.024 Tc
0.101 Tw
[(tif d\232nem (12.19\2612.94) ve post)1(o)1(p)1(er)1(a)1(t)1(i)1(f)]TJ
-3.68604 -1.27274 TD
0.018 Tc
0.107 Tw
[(10. aylar (11.96\2612.13) aras\335nda anlam)-1(l\335 bir fark)]TJ
0 -1.27272 TD
0 Tc
0 Tw
(bu)Tj
1 0.00001 TD
(lun)Tj
1.27784 0.00001 TD
[<6D616DDDDF>-1(t\335r \(p>0.05\) \(Tabl)1(o 3\). )]TJ
-2.27784 -2.54547 TD
0.037 Tc
0.088 Tw
[(Elektrokoagulas)-1(yon y\232ntemi ve mekanik klips)]TJ
0 -1.27272 TD
0.027 Tc
0.098 Tw
[(y\232ntemi ile tubal ste)-1(r)1(i)1(l)1(i)1(zasyon uygula)-1(nan hasta)]TJ
0 -1.27273 TD
0 Tc
0.038 Tw
[(gruplar\335)-1(n\335n postopera)-1(tif 10. ayda over rezerv belir-)]TJ
T*
0.02 Tc
0.105 Tw
[(te\215l)1(er)1(i)1(nin ort)1(a)1(l)1(ama de\333erl)1(e)1(r)1(inin kar\337\335la\337t)111(l)1(m)1(a)1<73DD>]TJ
0 -1.27272 TD
0 Tc
0 Tw
(tab)Tj
1.22168 0.00001 TD
(lo)Tj
1.0316 0.00001 TD
0.004 Tw
(4'de yer al)Tj
4.12961 0.00001 TD
0 Tw
(mak)Tj
1.72168 0.00001 TD
(ta)Tj
0.72167 0.00001 TD
0.004 Tw
[(d\335r. Elektrokoagulas)-1(yon y\232n-)]TJ
-8.82625 -1.27276 TD
0.042 Tw
[(temi ile tubal ste)-1(rilizas)-1(yon yap\335lan grupta postope-)]TJ
0 -1.27273 TD
0 Tw
(ra)Tj
0.77661 0.00001 TD
0.043 Tw
(tif 10. ay)Tj
3.66749 0.00001 TD
[(da \232l\215\237len orta)-1(lama total bazal over ha-)]TJ
-4.4441 -1.27274 TD
0.017 Tc
0 Tw
(cim)Tj
1.55072 0.00001 TD
0.108 Tw
[(leri, meka)-1(nik klips y\232ntemi uygula)-1(nan hasta)]TJ
-1.55072 -1.27273 TD
0 Tc
0 Tw
(gru)Tj
1.33276 -0.00001 TD
0.07 Tw
[(buna g\232re ista)-1(tistiksel olarak daha d\237\337\237k izlen-)]TJ
-1.33276 -1.27272 TD
0.006 Tc
0.119 Tw
[(di (p<0.05). Ayn\335 \337ekilde, ort)1(al)1(a)1(ma antral fol)1(ikul)]TJ
T*
0.008 Tc
0.117 Tw
[(s)1(a)1(y\335m\335 da me)-1(kanik klips uygul)1(a)1(nan grupta, elek-)]TJ
0 -1.27273 TD
0.003 Tc
0.122 Tw
[(trokoagulas)-1(yon uygulanan gruba g\232re istatis)-1(tiksel)]TJ
0 -1.27272 TD
0 Tc
0 Tw
[(olarak y\237ksek saptand\335 \(p<0.01\) \(Tab)-1(lo)-250(4\).)]TJ
ET
Q
q
BT
/F0 1 Tf
11 0 0 11 311.811 448.5374 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(TARTI\336MA)Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 311.811 420.5374 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(\334ler)Tj
1.38721 0 TD
(le)Tj
0.72168 0 TD
0.006 Tw
(yen ya\337)Tj
3.03247 0.00001 TD
(la be)Tj
1.9214 0 TD
0 Tw
(ra)Tj
0.77661 0 TD
0.006 Tw
(ber fe)Tj
2.30909 0.00001 TD
0 Tw
(kun)Tj
1.5 0 TD
0.006 Tw
[(ditenin azal)-1(d\335\333\335 iyi bi-)]TJ
-11.64846 -1.27275 TD
0.011 Tw
[(linen bir ger\215ek)-1(tir. \202in'de yap\335lan bir \215al\335\337mada or)-1(-)]TJ
0 -1.27273 TD
0.004 Tc
0 Tw
(ta)Tj
0.72951 0.00001 TD
0.121 Tw
[(lama antral fo)-1(likul say\335s\335nda her ilerle)-1(yen y\335lda)]TJ
-0.72951 -1.27273 TD
0.007 Tc
0.118 Tw
[(%)-374(3.8'lik bir d\237\337\237\337 oldu\333u bulunmu\337tur )]TJ
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 498.9414 381.1774 Tm
0 Tr
0 0 0 1 k
0.007 Tc
0 Tw
[(\(5)1(\))]TJ
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 508.4272 378.5374 Tm
0 Tr
0 0 0 1 k
0.0066 Tc
(.)Tj
0.63154 0 Td
0.007 Tc
0 Tw
(Over)Tj
-18.50574 -1.27273 TD
0.008 Tc
0.117 Tw
[(foli)-1(kullerinin yir)-1(minci intrauterin hafta)-1(dan ba\337la-)]TJ
0 -1.27272 TD
0 Tc
0 Tw
(ya)Tj
0.94384 0.00001 TD
0.108 Tw
(rak de)Tj
2.57875 0.00001 TD
(vam eden at)Tj
5.04761 0 TD
[(rezi)-1(si ve oosit say\335s\335n hi\215 bir)]TJ
-8.5702 -1.27274 TD
0.002 Tw
[(zaman artma)-1(yaca\333\335 ger\215ek)-1(leri g\232z \232n\237ne al\335nd\335\333\335n-)]TJ
0 -1.27272 TD
0.006 Tc
0.119 Tw
(da, ovar)Tj
3.38557 0.00001 TD
(yen pri)Tj
2.96383 0.00001 TD
[(mordial fo)-1(l)1(i)1(kul havuzunun inc)1(el)1(e)1(-)]TJ
-6.3494 -1.27274 TD
0.004 Tc
0.121 Tw
[(nerek de\333erlen)-1(dirilmesi)-1(nin, over rezervinin tama-)]TJ
0 -1.27273 TD
0 Tc
0.024 Tw
[(men t\237kendi\333i bir d\232nem olan me)-1(nopoz zaman\335n\335n)]TJ
0 -1.27272 TD
0.056 Tw
[(tahmin edilme)-1(sinde \232nemli bir rol\237 oldu\333u a\215\335kt\335r.)]TJ
0 -1.27273 TD
0.064 Tw
[(Menstruel siklu)-1(sun devam\335 i\215in en az 1000 folikul)]TJ
T*
0 Tw
[(gerekmek)-1(tedir )]TJ
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 378.3634 255.1774 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
((6))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 387.6876 252.5374 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
0.52574 0 Td
0.026 Tw
[(Folikul say\335)-1(s\335n\335n daha az oldu\333u)]TJ
-7.42361 -1.27272 TD
0 Tw
(du)Tj
1 0.00001 TD
(rum)Tj
1.6106 0.00001 TD
(lar)Tj
1.05444 0.00001 TD
0.112 Tw
(da mens)Tj
3.41646 0.00001 TD
0 Tw
(tru)Tj
1.1106 0.00001 TD
0.112 Tw
(el sikluslar durur ve menopoz)Tj
-8.1921 -1.27276 TD
0 Tw
(ba\337lar. )Tj
0 -2.54545 TD
(Ovar)Tj
1.99853 0.00001 TD
0.046 Tw
[(yen rezervi belir)-1(lemede kulla)-1(n\335lacak ideal pa)-1(-)]TJ
-1.99853 -1.27273 TD
0.011 Tc
0 Tw
(ra)Tj
0.79862 -0.00001 TD
0.114 Tw
[(metre kolay \232l\215\237)-1(lebilmeli, mi)-1(nimal invaziv ol-)]TJ
-0.79862 -1.27272 TD
0 Tc
0.036 Tw
[(mal\335, ucuz olma)-1(l\335 ve prediktif de\333eri y\237ksek olma)-1(-)]TJ
T*
0.105 Tw
[(l\335d\335r. Ultra)-1(sonografik de\333er)-1(lendirme h\335zl\335, g\237veni-)]TJ
0 -1.27273 TD
0.003 Tc
0.122 Tw
[(lir ve ucuz olmas\335n)-1(dan dolay\335 uygun bir y\232ntem-)]TJ
0 -1.27272 TD
0 Tc
0.022 Tw
[(dir. Total bazal over hacmi iler)-1(leyen ya\337 ile paralel)]TJ
ET
0 0 0 0 k
56.693 743.308 481.889 13.543 re
f
Q
q
BT
/F0 1 Tf
8 0 0 8 57.6929 749.8839 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Tablo 3. Mekanik klips grubu preoperatif d\232nem ve postoperatif 10. ay ovaryen rezerv belirte\215 de\333erleri kar\337\335la\337t\335r\335lmas\335.)Tj
ET
0 0 0 0 k
56.693 647.9471 141.732 90.695 re
f
Q
q
BT
/F1 1 Tf
8 0 0 8 57.6929 713.3785 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Bazal folikuler stimulan hormon (mIU/ml))Tj
0 -1.125 TD
(Bazal luteinizan hormon (mIU/ml))Tj
T*
(Bazal ekstradiol (pg/ml))Tj
T*
(Bazal inhibin-B (ng/ml))Tj
T*
(Bazal antimullerian hormon (ng/ml))Tj
T*
(Total bazal over hacmi \(cm)Tj
ET
Q
q
BT
/F1 1 Tf
6 0 0 6 145.6461 670.3585 Tm
0 Tr
0 0 0 1 k
0 Tc
(3)Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 148.6461 668.3785 Tm
0 Tr
0 0 0 1 k
0 Tc
(\))Tj
-11.36915 -1.125 TD
0 Tw
(Antral folikul say\335m\335)Tj
ET
0 J 0 j 10 M []0 d 1 w
0 0 0 1 K
56.693 743.1091 m
538.582 743.1091 l
S
0 0 0 0 k
279.622 647.933 75.78 90.708 re
f
Q
q
BT
/F0 1 Tf
8 0 0 8 282.7578 731.3777 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Preoperatif de\333erler )Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 301.2559 713.3777 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(6.72\2612.56)Tj
0 -1.125 TD
(6.12\2612.16)Tj
-0.5 -1.125 TD
(52.94\26125.69)Tj
T*
(87.42\26139.78)Tj
0.5 -1.125 TD
(2.68\2610.90)Tj
-0.25 -1.125 TD
(12.01\2612.90)Tj
T*
(12.19\2612.94)Tj
ET
0 0 0 0 k
431.316 647.946 107.267 90.695 re
f
Q
q
BT
/F0 1 Tf
8 0 0 8 436.7482 731.3777 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Postoperatif 10. ay de\333erleri)Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 468.6935 713.3777 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(6.81\2612.67)Tj
0 -1.125 TD
(6.22\2612.51)Tj
-0.5 -1.125 TD
(52.98\26125.91)Tj
T*
(85.32\26132.18)Tj
0.5 -1.125 TD
(2.54\2610.40)Tj
-0.25 -1.125 TD
(11.82\2612.21)Tj
T*
(11.96\2612.13)Tj
ET
0 J 0 j 10 M []0 d 1 w
0 0 0 1 K
56.693 725.2061 m
538.582 725.2061 l
S
56.693 648.063 m
538.582 648.063 l
S
0 0 0 0 k
56.693 614.965 481.889 13.542 re
f
Q
q
BT
/F0 1 Tf
8 0 0 8 57.6929 621.5404 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Tablo 4. Postoperatif 10. ay ovaryen rezerv belirte\215lerinin her iki grup aras\335nda kar\337\335la\337t\335r\335lmas\335.)Tj
ET
0 J 0 j 10 M []0 d 1 w
0 0 0 1 K
56.693 614.7661 m
538.582 614.7661 l
S
0 0 0 0 k
56.693 512.772 141.732 97.512 re
f
BT
/F0 1 Tf
8 0 0 8 57.6929 603.0201 Tm
0 0 0 1 k
(Preoperatif 10. ay)Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 57.6929 576.0201 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Bazal folikuler stimulan hormon (mIU/ml))Tj
0 -1.125 TD
(Bazal luteinizan hormon (mIU/ml))Tj
T*
(Bazal ekstradiol (pg/ml))Tj
T*
(Bazal inhibin-B (ng/ml))Tj
T*
(Bazal antimullerian hormon (ng/ml))Tj
T*
(Total bazal over hacmi \(cm)Tj
ET
Q
q
BT
/F1 1 Tf
6 0 0 6 145.6461 533.0002 Tm
0 Tr
0 0 0 1 k
0 Tc
(3)Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 148.6461 531.0201 Tm
0 Tr
0 0 0 1 k
0 Tc
(\))Tj
-11.36915 -1.125 TD
0 Tw
(Antral folikul say\335m\335)Tj
ET
0 0 0 0 k
263.622 512.757 75.78 97.526 re
f
Q
q
BT
/F0 1 Tf
8 0 0 8 267.2891 603.3162 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Elektrokoagulasyon )Tj
2.11902 -1.125 TD
((Ort.\261SD))Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 285.2559 576.3162 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(6.13\2612.90)Tj
0 -1.125 TD
(5.35\2612.01)Tj
-0.5 -1.125 TD
(50.26\26127.68)Tj
T*
(78.41\26132.88)Tj
0.5 -1.125 TD
(2.42\2610.25)Tj
-0.25 -1.125 TD
(10.80\2612.10)Tj
T*
(10.52\2612.34)Tj
ET
0 0 0 0 k
390.173 512.7711 66.205 97.512 re
f
Q
q
BT
/F0 1 Tf
8 0 0 8 398.717 603.3162 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Mekanik klips)Tj
0.91101 -1.125 TD
((Ort.\261SD))Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 407.0197 576.3162 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(6.81\2612.67)Tj
0 -1.125 TD
(6.22\2612.51)Tj
-0.5 -1.125 TD
(52.98\26125.91)Tj
T*
(85.32\26132.18)Tj
0.5 -1.125 TD
(2.54\2610.40)Tj
-0.25 -1.125 TD
(11.82\2612.21)Tj
T*
(11.96\2612.13)Tj
ET
0 0 0 0 k
505.967 512.7711 32.616 97.512 re
f
Q
q
BT
/F0 1 Tf
8 0 0 8 520.0514 603.0193 Tm
0 Tr
0 0 0 1 k
0 Tc
(p)Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 515.275 576.0193 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(0.26)Tj
0 -1.125 TD
(0.08)Tj
T*
(0.64)Tj
T*
(0.32)Tj
T*
(0.07)Tj
-0.25 -1.125 TD
(0.03*)Tj
-0.5 -1.125 TD
(0.003**)Tj
ET
0 0 0 0 k
56.693 480.235 481.89 28.697 re
f
Q
q
BT
/F2 1 Tf
8 0 0 8 57.6929 501.9727 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Unpaired t-testi uygulanm\335\337t\335r.)Tj
0 -1.125 TD
(*p<0.05 )Tj
T*
(**p<0.01)Tj
ET
0 J 0 j 10 M []0 d 1 w
0 0 0 1 K
56.693 512.906 m
538.583 512.906 l
S
56.693 588.848 m
538.582 588.848 l
S
0 0 0 0 k
56.693 789.197 481.89 10.173 re
f
BT
/F2 1 Tf
8 0 0 8 57.6929 792.4114 Tm
0 0 0 1 k
(N. S\237er ve ark., Tubal sterilizasyonda elektrokoag\237lasyon ve mekanik klips y\232ntemlerinin over rezervine etkilerinin kar\337\335la\337t\335r\335lmas\335)Tj
ET
0 0 0 0 k
521.575 92.544 17.0079 12.338 re
f
Q
q
BT
/F0 1 Tf
10 0 0 10 522.5747 96.4239 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(129)Tj
ET
Q
endstream
endobj
7 0 obj
<<
/Length 12057
>>
stream
/GS0 gs
q
0 0.89 595 841 re
W n
1 g
0 841.89 0 0 re
f
Q
/GS1 gs
q
0 0 0 0 k
56.693 119.055 481.89 637.796 re
f
Q
q
BT
/F1 1 Tf
11 0 0 11 57.6929 747.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
0.029 Tw
[(olarak azal\335r. Menstru)-1(lasyonun erken folikul faz\335n)-1(-)]TJ
0 -1.27273 TD
0.0054 Tc
(d)Tj
0.50539 -0.00001 TD
0.005 Tc
0.119 Tw
[(aki antral foli)-1(kul say\335s\335nda azalma hen\237z se)-1(rum)]TJ
-0.50539 -1.27272 TD
0.003 Tc
0.122 Tw
[(bazal FSH de\333erle)-1(ri artmam\335\337)-1(ken izlenebilmekte)-1(-)]TJ
0 -1.27273 TD
0 Tc
0.106 Tw
[(dir. Folikul)-1(ler inaktif dinlenme evresin)-1(den ge\215tik-)]TJ
T*
0.116 Tw
[(ten sonra en az 2 mili)-1(metrelik boyutla)-1(ra ula\337\335rlar.)]TJ
0 -1.27272 TD
0.002 Tc
0.123 Tw
[(Bu boyutl)1(a)1(r)1(d)1(aki fol)1(i)1(kull)1(e)1(r)1(,)1( )1(u)1(l)1(t)1(r)1(ason ile g\232r)1<9F>1(n)1(t)1<9F>1(l)1(e)1(-)]TJ
0 -1.27273 TD
0 Tc
0.006 Tw
[(nebilir)-1(ler. Menstrulasyon siklusu boyunca ar)-1(tan se-)]TJ
T*
0.019 Tw
[(rum FSH seviyesi)-1(nin etkisiyle, bu antral foli)-1(kuller-)]TJ
T*
0.05 Tw
[(den inhibin B ve estra)-1(diol salg\335lan\335r )]TJ
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 221.0521 637.8781 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
((7))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 230.3763 635.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
0.5498 0 Td
0 Tw
<479F6E9F6D9F7A2D>Tj
-16.24829 -1.27272 TD
0.113 Tw
[(de kullan\335)-1(lan over rezerv parametre)-1(leri)-1(ni kar\337\335la\337-)]TJ
0 -1.27273 TD
0.084 Tw
[(t\335rmak amac\335y)-1(la Bansci ve ark, ilk defa IVF yap\335-)]TJ
0 -1.27272 TD
0.032 Tw
[(lan 120 hastada, menstru)-1(lasyon siklusu 3. g\237n\237 se-)]TJ
0 -1.27273 TD
0.102 Tw
[(rum bazal FSH, E2 ve inhibin B sevi)-1(yeleri ile ul-)]TJ
T*
0.006 Tc
0.119 Tw
[(trasonogra)-1(fik olarak \232l\215\237len antral foli)-1(kul say\335m\335)]TJ
0 -1.27272 TD
0.011 Tc
0.114 Tw
[(ve total bazal ovaryen hacim)-1(l)1(e)1(r)1(i)1(ni de)-1(\333erlendirdi.)]TJ
0 -1.27273 TD
0 Tc
0.006 Tw
[(Bu \215al\335\337ma)-1(n\335n sonu\215lar\335 azalm\335\337 over rezer)-1(vinin en)]TJ
T*
0.005 Tw
[(iyi g\232sterges)-1(inin antral folikul say\335)-1(s\335 d\237\337mesi oldu-)]TJ
0 -1.27271 TD
0.056 Tw
[(\333unu g\232stermi\337)-1(tir. Yine ayn\335 \215al\335\337mada antral fo)-1(li-)]TJ
0 -1.27273 TD
0.003 Tc
0.122 Tw
[(kul say\335m\335)-1(n\335n, bazal serum FSH ve inhibin B \232l-)]TJ
T*
0.019 Tc
0.106 Tw
[(\215\237mleriy)-1(le beraber de\333er)-1(lendirildi\333inde da)-1(ha da)]TJ
T*
0 Tc
0.103 Tw
[(g\237venilir oldu\333unu or)-1(taya konulmu\337tur )]TJ
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 237.5883 469.8781 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
((8))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 246.9125 467.2382 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(.)Tj
0.60296 0 Td
0 Tc
0 Tw
[(Litera)-1(-)]TJ
-17.80474 -1.27273 TD
0.117 Tw
[(t\237rdeki over rezer)-1(vi ile ilgili \215al\335\337ma)-1<6C6172DD6E20DDDFDDDBDD6E6461>]TJ
T*
0.113 Tw
[(biz de \215al\335\337ma)-1(m\335zda, over rezervi belir)-1(te\215leri ola-)]TJ
0 -1.27272 TD
0.111 Tw
(rak se)Tj
2.47083 0 TD
[(rum bazal FSH, LH, estradi)-1(ol, inhibin B ve)]TJ
-2.47083 -1.27273 TD
0.01 Tc
0.115 Tw
[(ant)1(imull)1(e)1(r)1(i)1(an hor)-1(mon de\333erl)1(e)1(r)1(ini ve transvaginal)]TJ
T*
0.02 Tc
0 Tw
(ul)Tj
0.81815 0.00001 TD
(tra)Tj
1.11492 0.00001 TD
(so)Tj
0.92923 0 TD
(nog)Tj
1.56047 0 TD
(ra)Tj
0.81692 0.00001 TD
0.105 Tw
(fik de)Tj
2.53024 0 TD
0 Tw
(\333er)Tj
1.33708 0 TD
0.105 Tw
[(lendirme ile sap)-1(tanan total)]TJ
-9.107 -1.27274 TD
0 Tc
0 Tw
(ba)Tj
0.94385 0.00001 TD
0.001 Tw
(zal over hac)Tj
4.83124 0 TD
0 Tw
(mi)Tj
1.05566 0 TD
0.001 Tw
(ni ve an)Tj
3.16693 0.00001 TD
[(tral foli)-1(kul say\335m\335n\335 kulla-)]TJ
-9.99768 -1.27274 TD
0.001 Tc
0.124 Tw
[(d\335k. Dinamik, invaziv ve paha)-1(l\335 testler olmala)-1(r\335n-)]TJ
0 -1.27272 TD
0.016 Tc
0.109 Tw
(dan do)Tj
2.89904 0 TD
[(lay\335 klomi)-1(fen sitrat uyarma testi (CCST),)]TJ
-2.89904 -1.27273 TD
0.002 Tc
0.123 Tw
[(GnRH agonist stimulas)-1(yon testi (GAST), eksojen)]TJ
0 -1.27272 TD
0 Tc
0.057 Tw
(FSH over re)Tj
5.00009 0.00001 TD
0 Tw
(zer)Tj
1.22046 0.00001 TD
0.057 Tw
(vi test)Tj
2.47282 0.00001 TD
0 Tw
(le)Tj
0.72168 0.00001 TD
0.057 Tw
(ri (EFORT) ter)Tj
6.1102 0.00001 TD
(cih et)Tj
2.24993 0.00001 TD
0 Tw
(medik.)Tj
-17.77518 -1.27276 TD
0.064 Tw
[(Uygulama zor)-1(lu\333u ve standardizasyon problem)-1(leri)]TJ
0 -1.27272 TD
0 Tw
(ne)Tj
0.94385 0.00001 TD
(de)Tj
0.94385 0.00001 TD
(niy)Tj
1.27783 0.00001 TD
0.09 Tw
[(le Doppler ultraso)-1(nografi ile ovaryen stro-)]TJ
-3.16553 -1.27274 TD
0.104 Tw
(mal kan ak\335)Tj
4.87229 0.00001 TD
[(m\335 y\232ntemi)-1(ni de kullanmay\335 tercih et)-1(-)]TJ
-4.87229 -1.27274 TD
0 Tw
(medik.)Tj
0 -2.54545 TD
0.029 Tw
[(Alvarez ve ark)-1(.)-278(ta)-1(raf\335ndan 1989 y\335l\335nda yay\335nlanan)]TJ
0 -1.27273 TD
0.024 Tw
[<8D616CDDDF>-1(ma tubal sterili)-1(zasyonun over rezervine etki)-1(le-)]TJ
T*
0.034 Tw
[(rini ara\337)-1(t\335ran ilk klinik \215al\335\337ma)-1(lardan biridir )]TJ
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 255.4271 217.8781 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
((9))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 264.7513 215.2381 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
0.53421 0 Td
0 Tw
(Bu)Tj
-19.3577 -1.27273 TD
<8D61>Tj
0.8877 0.00001 TD
<6CDDDF>Tj
0.94457 0.00001 TD
(ma)Tj
1.22168 0.00001 TD
0.044 Tw
(da, 8 has)Tj
3.61515 0.00001 TD
[(taya Pome)-1(roy y\232ntemi ve 9 hasta-)]TJ
-6.6691 -1.27275 TD
0.001 Tc
0.124 Tw
[(ya Uchida y\232nte)-1(mi ile tubal sterili)-1(zasyon uygula-)]TJ
0 -1.27273 TD
0.018 Tc
0 Tw
(na)Tj
0.9796 0.00001 TD
0.107 Tw
[(rak, postoper)1(atif 2.)-375(ve 6. aylarda serum ba)-1(zal)]TJ
-0.9796 -1.27273 TD
0.021 Tc
0.104 Tw
[(FSH, LH ve estradi)-1(ol seviyeler)1(ine bak\335lm\335\337. \334ki)]TJ
T*
0 Tc
0.102 Tw
[(tekni\333in over rezer)-1(vi parametre)-1(leri \237zeri)-1(ne istatis-)]TJ
T*
0.066 Tw
[(tiksel olarak anlam)-1(l\335 etkileri iz)-1(lenmemi\337tir. Bu \215a-)]TJ
23.10165 56 TD
0.025 Tc
0.1 Tw
[<6CDDDF6D61>-1(n\335n en \232nemli dezavantajla)-1(r\335 k\335s\335tl\335 say\335da)]TJ
0 -1.27273 TD
-0.0001 Tc
(h)Tj
0.49988 -0.00001 TD
0 Tc
0.033 Tw
[(asta grubu ile \215al\335)-1(\337\335lm\335\337 olmas\335 ve ovaryen re)-1(zerv)]TJ
-0.49988 -1.27272 TD
0.004 Tc
0.121 Tw
[(belirte\215)-1(lerinin yeter)-1(li \337ekilde de\333erlen)-1(dirilmeme)-1(si)]TJ
0 -1.27273 TD
0 Tc
0.051 Tw
[(say\335la)-1(bilir. 20 hastaya mini)-1(laparotomi ile Po)-1(meroy)]TJ
T*
0.007 Tc
0.118 Tw
[(tekni\333i ile tubal ste)-1(rilizas)-1(yon uygulad\335klar\335 \215al\335\337)-1(-)]TJ
0 -1.27272 TD
0 Tc
0.011 Tw
[(mala)-1(r\335nda Gebel ve ark, preopera)-1(tif ve postoperatif)]TJ
0 -1.27273 TD
0.004 Tc
0.121 Tw
[(d\232nemler aras\335nda ovaryen ar)-1(ter PI de\333erleri a\215\335-)]TJ
T*
0 Tc
0.07 Tw
[(s\335ndan ista)-1(tistiksel olarak anlaml\335 bir fark bula)-1(ma-)]TJ
T*
0 Tw
(m\335\337lard\335r )Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 354.2668 637.8781 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
((10))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 367.591 635.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
-5.07091 -2.54546 TD
0.009 Tc
0.116 Tw
[(Carmona ve ark)-1(.)-375(taraf\335n)-1(dan 2003 y\335l\335nda yap\335lan)]TJ
0 -1.27272 TD
0 Tc
0.033 Tw
[(di\333er bir \215al\335\337)-1(mada 26 hastaya bipolar elektro)-1(kote-)]TJ
0 -1.27273 TD
0.038 Tw
[(rizas)-1(yon ile tubal sterili)-1(zasyon yap\335lm\335\337, ayn\335 say\335-)]TJ
T*
0.098 Tw
[(da olu\337turulan kon)-1(trol grubuyla beraber vaka gru-)]TJ
0 -1.27272 TD
0.052 Tw
[(bunda preopera)-1(tif d\232nemde serum bazal FSH, LH,)]TJ
0 -1.27273 TD
0.032 Tc
0.093 Tw
[(estra)-1(diol ve inhibin B seviyele)-1(rine bak\335lm\335\337)-1(t\335r.)]TJ
T*
0 Tc
0.011 Tw
[(Postopera)-1(tif 6., 12., 18., 24. ve 60. aylarda ovaryen)]TJ
0 -1.27271 TD
0.014 Tc
0.111 Tw
[(r)1(e)1(zerv be)-1(l)1(i)1(r)1(te\215l)1(e)1(ri ile preope)-1(r)1(a)1(tif d\232nemde tespit)]TJ
0 -1.27273 TD
0 Tc
0.098 Tw
[(edilen de\333erler ara)-1(s\335nda istatisti)-1(ki anlaml\335 bir fark)]TJ
T*
0.018 Tc
0 Tw
[(izlenme)-1(mi\337tir )]TJ
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 379.0613 483.8781 Tm
0 Tr
0 0 0 1 k
0.019 Tc
0 Tw
[(\()1(11\))]TJ
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 392.9778 481.2381 Tm
0 Tr
0 0 0 1 k
0.0184 Tc
(.)Tj
0.64336 0 Td
0.018 Tc
0.106 Tw
[(Dede ve ark.)-376(taraf\335n)-1(dan buna)]TJ
-8.02216 -1.27273 TD
0 Tc
0.068 Tw
[(benzer bir \215al\335\337ma da \237l)-1(kemizde ger\215ekle\337ti)-1(rilmi\337-)]TJ
T*
0 Tw
(tir )Tj
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 325.073 455.8781 Tm
0 Tr
0 0 0 1 k
0 Tc
(\()Tj
0.33276 0 TD
0 Tw
(12)Tj
1 0 TD
(\))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 338.3972 453.2381 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(.)Tj
0.56709 0 Td
0 Tc
0.067 Tw
[(Bipolar elektrokote)-1(rizasyon y\232nte)-1(mi ile tu-)]TJ
-2.98402 -1.27273 TD
0.015 Tw
[(bal steri)-1(lizasyon yap\335lan 60 hasta)-1(da preoperatif d\232-)]TJ
0 -1.27272 TD
0 Tw
(nem)Tj
1.72168 0 TD
0.021 Tw
[(de serum bazal FSH, LH ve estra)-1(diol seviyele)-1(-)]TJ
-1.72168 -1.27273 TD
0.02 Tc
0.105 Tw
[(rine ba)-1(k\335lm\335\337, postopera)-1(tif 3. ayda tekrar edilen)]TJ
T*
0 Tc
0 Tw
(ovar)Tj
1.77661 0.00001 TD
0.009 Tw
(yen re)Tj
2.47938 0.00001 TD
(zerv be)Tj
2.92323 0 TD
0 Tw
(lir)Tj
0.88843 0 TD
(te\215)Tj
1.16552 0.00001 TD
(le)Tj
0.72168 0 TD
(rin)Tj
1.11059 0 TD
0.009 Tw
[(de istatis)-1(tiksel herhangi)]TJ
-11.06545 -1.27274 TD
0.043 Tw
(bir fark iz)Tj
4.02785 0.00001 TD
0 Tw
(len)Tj
1.22167 0 TD
(me)Tj
1.22168 0 TD
(mi\337)Tj
1.44458 0.00001 TD
0.043 Tw
[(tir. Bipolar elektrokote)-1(rizasyon)]TJ
-7.91579 -1.27274 TD
0.034 Tw
[(uygulanan bu iki \215al\335\337)-1(mada over rezerv belirte\215)-1(leri)]TJ
0 -1.27272 TD
0.003 Tc
0 Tw
(ola)Tj
1.22978 0 TD
0.122 Tw
[(rak hormonal bel)1(i)1(rt)1(e)1<8D>1(ler kull)1(a)1(n\335l)-1(m\335\337 ve her iki)]TJ
-1.22978 -1.27273 TD
0 Tc
0.009 Tw
[<8D616CDDDF>-1(mada da istatistik)-1(sel olarak anlaml\335 bir fark iz-)]TJ
0 -1.27272 TD
0.075 Tc
0 Tw
(len)Tj
1.44667 0.00001 TD
(me)Tj
1.37167 0.00001 TD
(mi\337)Tj
1.66957 0.00001 TD
0.247 Tw
(tir. Yi)Tj
3.15986 0.00001 TD
(ne \237l)Tj
2.59337 0.00001 TD
0 Tw
(ke)Tj
1.09384 0.00001 TD
0.247 Tw
(mizden Kelek\215i ve)Tj
-11.33499 -1.27276 TD
0 Tc
0.125 Tw
[(ark.\325lar\335n\335n)-375(74 hastaya elek)-1(trokoagulasyonla tubal)]TJ
0 -1.27272 TD
0.003 Tc
0 Tw
(ste)Tj
1.11915 0.00001 TD
0.002 Tc
(ri)Tj
0.61631 0.00001 TD
0.003 Tc
(li)Tj
0.56137 0.00001 TD
0.122 Tw
[(zasyon uygula)-1<64DD>1(k)-1(lar\335 \215al\335\337ma)-1(lar\335nda preope-)]TJ
-2.29683 -1.27274 TD
0 Tc
0 Tw
(ra)Tj
0.77661 0.00001 TD
0.033 Tw
[(tif erken foli)-1(kuler serum bazal FSH, LH, estradi-)]TJ
-0.77661 -1.27274 TD
0.004 Tc
0.121 Tw
[(ol seviyel)1(eri ile total bazal ovaryen hacmi, ant)1(r)1(a)1(l)]TJ
0 -1.27272 TD
0 Tc
0.072 Tw
[(foli)-1(kul say\335m\335 ve ovaryen stromal kan ak\335m dopp-)]TJ
0 -1.27273 TD
0.002 Tw
[(ler indeksle)-1<7269209A6C8D9F6C6D9FDF749F7220>]TJ
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 427.6557 245.8781 Tm
0 Tr
0 0 0 1 k
0 Tc
(\()Tj
0.33276 0.00001 TD
0 Tw
(13)Tj
1 0.00001 TD
(\))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 440.9799 243.2381 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
0.5023 0 Td
0.002 Tw
[(Postopera)-1(tif ilk ayda)]TJ
-12.24492 -1.27273 TD
0.022 Tc
0.103 Tw
[(serum bazal FSH sevi)-1(yeleri ve ovaryen stromal)]TJ
T*
0.028 Tc
0.097 Tw
[(pulsati)-1(lite indeksleri pre)-1(oper)1(a)1(tif d\232nemdeki \232l-)]TJ
T*
0.001 Tc
0 Tw
<8D9F6D>Tj
1.72502 0.00001 TD
(ler)Tj
1.05778 0.00001 TD
0.124 Tw
(den ve kon)Tj
4.64661 0.00001 TD
(trol gru)Tj
3.10398 0.00001 TD
[(bundaki \232l\215\237mler)-1(den is-)]TJ
-10.5334 -1.27275 TD
0 Tc
0.019 Tw
[(tatis)-1(tiki olarak anlaml\335 olarak y\237k)-1(sek bulundu. An-)]TJ
0 -1.27273 TD
0.008 Tc
0.117 Tw
(cak pos)Tj
3.20224 0.00001 TD
[(topera)-1(tif 12. ayda tekrarla)-1(nan \232l\215\237mlerde)]TJ
-3.20224 -1.27273 TD
0.022 Tc
0.103 Tw
[(hormaonal ovaryen rezerv be)-1(lirte\215leri a\215\335)-1(s\335ndan)]TJ
T*
0 Tc
0.098 Tw
[(hasta ve kontrol grupla)-1(r\335 aras\335nda fark\335n tamamen)]TJ
T*
0.015 Tc
0.11 Tw
[(kayboldu\333u ve ista)-1(tistiksel olarak hi\215bir anlaml\335)]TJ
ET
0 0 0 0 k
402.52 789.197 136.063 10.173 re
f
Q
q
BT
/F2 1 Tf
8 0 0 8 403.5198 792.4114 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(G\232ztepe T\335p Dergisi 23(4):126-132, 2008)Tj
ET
0 0 0 0 k
56.693 92.544 17.008 12.338 re
f
Q
q
BT
/F0 1 Tf
10 0 0 10 57.6929 96.4236 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(130)Tj
ET
Q
endstream
endobj
8 0 obj
<<
/Length 11445
>>
stream
/GS0 gs
q
0 0.89 595 841 re
W n
1 g
0 841.89 0 0 re
f
Q
/GS1 gs
q
0 0 0 0 k
56.693 119.055 481.89 637.796 re
f
Q
q
BT
/F1 1 Tf
11 0 0 11 57.6929 747.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
0.078 Tw
[(fark bulunma)-1(d\335\333\335 saptanm\335\337t\335r. Buna ra\333men, pos-)]TJ
0 -1.27273 TD
-0.0002 Tc
(t)Tj
0.27783 -0.00001 TD
0 Tc
0.092 Tw
[(opera)-1(tif 12. ayda ortala)-1(ma total bazal over hacmi)]TJ
-0.27783 -1.27272 TD
0.117 Tw
[(ve antral foli)-1(kul say\335mlar\335)-1(n\335n anlaml\335 olarak azal-)]TJ
0 -1.27273 TD
0 Tw
[(m\335\337 oldu\333u izlenmi\337)-1(tir.)]TJ
0 -2.54546 TD
0.008 Tc
0.116 Tw
[(Over rezervi belir)-1(te\215leri \237zeri)-1(ne litera)-1(t\237rd)-1(e)-1( )-1(b)-1(u)-1(lu-)]TJ
0 -1.27273 TD
0 Tc
0.112 Tw
[(nan \215al\335\337ma)-1(larda ortaya \215\335kan sonu\215, bozu)-1(lan pri-)]TJ
T*
0.006 Tc
0.119 Tw
[(mordial fo)-1(likul havuzunun en erken g\232sterge)-1(leri-)]TJ
T*
0 Tc
0.089 Tw
[(nin ultrasonogra)-1(fik total bazal over hacim \232l\215\237m\237)]TJ
0 -1.27272 TD
0.082 Tw
[(ve antral foli)-1(kul say\335m\335 oldu\333udur )]TJ
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 215.2564 623.8782 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
((14,15))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 238.5806 621.2382 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(.)Tj
0.58205 0 Td
0 Tc
0.082 Tw
(Son lite-)Tj
-17.02638 -1.27273 TD
0.023 Tw
[(rat\237r)-1(lerin \335\337\335\333\335nda, biz de \215al\335\337ma)-1(m\335zda, elektroko-)]TJ
0 -1.27272 TD
0.005 Tc
0.12 Tw
[(agulasyon y\232nte)-1(mi ile tubal ster)1(i)1(li)-1(zasyon uygula-)]TJ
0 -1.27273 TD
0.001 Tc
0.124 Tw
[(nan hastalar)-1(da ultrasonogra)-1(fik ovaryen rezerv be-)]TJ
T*
0 Tc
0.092 Tw
[(lirte\215)-1(lerinin etki)-1(lenmesine ra\333men hormo)-1(nal ovar-)]TJ
0 -1.27272 TD
0.098 Tw
[(yen belirte\215)-1(lerinin de\333i\337)-1(memesinden dola)-1(y\335, ultra-)]TJ
0 -1.27273 TD
0.023 Tw
[(sonografik pa)-1(rametre)-1(lerin azalan overyen rezer)-1(vini)]TJ
T*
0.051 Tw
[(g\232steren er)-1(ken belirte\215ler oldu\333u sonucuna var)-1(d\335k.)]TJ
0 -1.27271 TD
0.011 Tw
[(Postopera)-1(tif 10. ayda, ki bu aydan sonra hasta taki-)]TJ
0 -1.27273 TD
0.043 Tw
[(bine devam edilme)-1(mi\337tir, ultrasonogra)-1(fik paramet)-1(-)]TJ
T*
0.018 Tc
0.107 Tw
[(rele)-1(rin-azalan over rezervi)-1(nin erken belirte\215le)-1(ri-)]TJ
T*
0 Tc
0.057 Tw
[(azald\335\333\335, ancak hor)-1(monal belirte\215le)-1(rin de\333i\337medi\333i)]TJ
T*
0.039 Tw
[(izlenmi\337)-1(tir. B\237y\237k ihtimalle hor)-1(monal ovaryen be-)]TJ
T*
0.057 Tw
[(lirte\215)-1(ler de ilerleyen aylarda azala)-1(cakt\335r. Ancak bu)]TJ
0 -1.27272 TD
0 Tw
(hi)Tj
0.77784 0 TD
0.023 Tw
[(potezin do\333ru)-1(lanmas\335 i\215in uzun vadeli \215al\335\337)-1(mala-)]TJ
-0.77784 -1.27273 TD
0 Tw
[(r\335n yap\335lma)-1(s\335 gerekmektedir.)]TJ
0 -2.54545 TD
0.002 Tc
<8261>Tj
1.11495 0.00001 TD
<6CDDDF>Tj
0.95074 0 TD
0.0017 Tc
(ma)Tj
1.22579 0 TD
0.002 Tc
(m\335z)Tj
1.50567 0.00001 TD
0.123 Tw
[(da elektrokoagulas)-1(yon y\232ntemi ile tu-)]TJ
-4.79715 -1.27274 TD
0.009 Tc
0.116 Tw
[(bal steri)-1(lizasyon yap\335lan hasta grubuyla me)-1(kanik)]TJ
0 -1.27272 TD
0.005 Tc
0.12 Tw
(klips y\232n)Tj
3.85932 0 TD
[(temi uygula)-1(nan hastalar aras\335n)-1(da ortala-)]TJ
-3.85932 -1.27273 TD
0 Tc
0.107 Tw
[(ma ya\337 bak\335m\335ndan is)-1(tatistiksel olarak anlam)-1(l\335 bir)]TJ
0 -1.27272 TD
0.007 Tc
0.118 Tw
(fark iz)Tj
2.74648 0.00001 TD
0 Tw
(len)Tj
1.24189 0.00001 TD
0.006 Tc
(me)Tj
1.23515 0.00001 TD
0.007 Tc
0.118 Tw
(di. Her iki gru)Tj
6.12065 0.00001 TD
(bun da ya\337 or)Tj
5.80175 0.00001 TD
0.006 Tc
0 Tw
(ta)Tj
0.73515 0.00001 TD
[(lama)-1<73DD>]TJ
-17.88107 -1.27276 TD
0 Tc
0.084 Tw
[(37 y\335l civar\335nday)-1(d\335. Mekanik klips y\232ntemi ile tu-)]TJ
0 -1.27272 TD
0.003 Tc
0.122 Tw
(bal ste)Tj
2.72805 0.00001 TD
0 Tw
(ri)Tj
0.61753 0.00001 TD
(li)Tj
0.56259 0.00001 TD
0.122 Tw
[(zasyon yap\335lan hasta)-1(lar\335n preopera)-1(tif ile)]TJ
-3.90817 -1.27274 TD
0 Tc
0 Tw
(pos)Tj
1.38892 0.00001 TD
0.076 Tw
[(topera)-1(tif 10. ay ovaryen rezerv belirte\215)-1(leri ara-)]TJ
-1.38892 -1.27274 TD
0.004 Tc
0.121 Tw
[(s\335nda ist)1(atist)1(i)1(ki bir fark izlenm)1(edi. B\232yl)1(e)1(likle, bu)]TJ
0 -1.27272 TD
0 Tc
0.052 Tw
[(metodun ovar)-1(yen rezerve olumsuz herhangi bir et-)]TJ
0 -1.27273 TD
0.006 Tw
[(kisi saptanma)-1(m\335\337 olundu. Timomen ve arkada\337la)-1(r\335-)]TJ
T*
0.073 Tw
[(n\335n yapt\335kla)-1(r\335 \215al\335\337mada, mekanik klips uy)-1(gulanan)]TJ
T*
0.005 Tc
0.12 Tw
[(33 hastada pre)-1(oper)1(a)1(tif d\232nem ve postope)-1(r)1(a)1(tif 12.)]TJ
T*
0.019 Tc
0.106 Tw
(ay se)Tj
2.22668 0.00001 TD
(rum ba)Tj
3.02329 0.00001 TD
(zal FSH, LH ve es)Tj
8.10263 0.00001 TD
0.018 Tc
0 Tw
(tra)Tj
1.11075 0.00001 TD
0.019 Tc
0.106 Tw
[(diol sevi)-1(yel)1(e)1(r)1(i)]TJ
-14.46334 -1.27275 TD
0.022 Tc
0.103 Tw
[(aras\335nda is)-1(tatistiksel bir fark g\232r\237l)-1(memi\337tir )]TJ
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 266.6815 189.8782 Tm
0 Tr
0 0 0 1 k
0 Tc
(\()Tj
0.35493 0.00001 TD
0.022 Tc
0 Tw
(16)Tj
1.0443 0.00001 TD
0 Tc
(\))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 280.7147 187.2381 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
-20.27471 -1.27273 TD
0.011 Tc
0 Tw
(Bu)Tj
1.18911 0.00001 TD
0.114 Tw
[(na benzer olarak, tubal steri)-1(lizasyon amac\335y)-1(la)]TJ
-1.18911 -1.27273 TD
0 Tc
0.098 Tw
[(Thranov ve arkada\337)-1(lar\335n\335n fallo)-1(pian halka ve fisc-)]TJ
T*
0.076 Tw
[(hie klips kulland\335k)-1(lar\335 ba\337ka bir \215al\335\337ma)-1(da, her iki)]TJ
T*
0.052 Tw
[(metodun da ovar)-1(yen rezerv belirte\215le)-1(ri \237zerine an-)]TJ
23.10165 55.97354 TD
0.064 Tw
[(laml\335 etki)-1(lerinin olma)-1(d\335\333\335 saptanm\335\337t\335r )]TJ
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 486.2893 749.587 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
((17))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 499.6136 746.9471 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
0.56351 0 Td
0 Tw
(Sumia-)Tj
-17.63647 -1.27273 TD
0.001 Tc
0.124 Tw
[(la ve arkada\337la)-1(r\335n\335n yay\335nla)-1(d\335klar\335 mekanik klips-)]TJ
T*
0.012 Tc
0.113 Tw
[(lerin kulla)-1<6EDD6C64DDDBDD208D616CDDDF6D61>-1(da ise, 16 hastan\335n pre-)]TJ
0.0014 Tc
(o)'
0.50142 -0.00001 TD
0.001 Tc
0.124 Tw
[(peratif d\232)-1(nem ovaryen arter diren\215 \232l\215\237mle)-1(ri ile)]TJ
-0.50142 -1.27273 TD
0 Tc
0.029 Tw
[(erken posto)-1(peratif d\232nem ve posto)-1(peratif 3. aydaki)]TJ
0 -1.27272 TD
0.001 Tc
0.124 Tw
[<9A6C8D9F6D6C6572>-1(le kar\337\335la\337t\335r\335l)-1(m\335\337t\335r. Hem erken postope-)]TJ
0 -1.27273 TD
0.003 Tc
0.122 Tw
[(ratif d\232)-1(nemde, hem de 3. postoperatif ay)-1(da ovar-)]TJ
T*
0.014 Tc
0.111 Tw
[(yen arter diren\215 \232l\215\237m)-1(l)1(e)1(rinde ist)1(at)1(i)1(s)1(tiksel olarak)]TJ
T*
0 Tc
0.021 Tw
[(anlaml\335 bir ar)-1(t\335\337 izlenmi\337tir )]TJ
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 434.9061 637.587 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
((18))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 448.2303 634.947 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(.)Tj
0.52066 0 Td
0 Tc
0.021 Tw
[(Mekanik klipsle)-1(rin)]TJ
-12.92241 -1.27272 TD
0.005 Tw
[(kullan\335l)-1(d\335\333\335 bu \215al\335\337man\335n en b\237y\237k deza)-1(vantaj\335 ta-)]TJ
0 -1.27273 TD
0.072 Tw
[(kip s\237reci)-1(nin postopera)-1(tif \237\215 ayl\335k k\335sa bir zaman\335)]TJ
0 -1.27272 TD
0.005 Tc
0.12 Tw
[(kapsama)-1(s\335d\335r. Tubal sterili)-1(zasyon i\337lemle)-1(rinin er-)]TJ
0 -1.27273 TD
0.016 Tc
0.109 Tw
[(ken postopera)-1(tif d\232nemde ovaryen arter doppler)]TJ
T*
0 Tc
0.046 Tw
[(indeksle)-1(rinde art\335\337a neden olabi)-1(lece\333i bir\215ok \215al\335\337)-1(-)]TJ
T*
0.004 Tw
[(mada g\232ste)-1(rilmi\337tir )]TJ
ET
Q
q
BT
/F1 1 Tf
8 0 0 8 399.883 553.587 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
((13,19))Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 423.2073 550.947 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(.)Tj
0.50427 0 Td
0 Tc
0.004 Tw
[(Litera)-1(t\237rdeki b\237t\237n veri)-1(-)]TJ
-10.6312 -1.27272 TD
0.009 Tc
0.116 Tw
[<6C6572696E20DDDFDDDBDD6E>-1(da, bizim \215al\335\337mam\335z)-1<64616E208DDD6B61727474DDDBDD6DDD7A>]TJ
0 -1.27273 TD
0.003 Tc
0.122 Tw
[(sonu\215, mekanik klips y\232nte)-1(mi ile tubal sterili)-1(zas-)]TJ
0 -1.27272 TD
0 Tc
0.123 Tw
[(yonun postopera)-1(tif d\232nemde over rezervi)-1(ne kal\335c\335)]TJ
0 -1.27273 TD
0.018 Tc
0.107 Tw
[(olumsuz bir etkisi)-1(nin olmad\335\333\335d\335r. Sa)-1(dece erken)]TJ
T*
0 Tc
0.125 Tw
[(postopera)-1(tif d\232nemde utero-ovaryen anasto)-1(mozla-)]TJ
T*
0.089 Tw
[(r\335n t\335kanma)-1(s\335na ba\333l\335 ovaryen arter direncin)-1(de ge-)]TJ
0 -1.27272 TD
0 Tw
<8D69>Tj
0.72168 0.00001 TD
0.047 Tw
[(ci bir art\335\337 g\232r\237le)-1(bilmesi)-1(ne ra\333men, bu bulgunun)]TJ
-0.72168 -1.27273 TD
0.084 Tw
[(ilerle)-1(yen aylarda kaybolmas\335n)-1(dan dolay\335, mekanik)]TJ
T*
0.101 Tw
[(klips y\232ntemiy)-1(le tubal sterili)-1(zasyonla over rezervi)]TJ
T*
0 Tw
(uzun va)Tj
3.1377 0 TD
(de)Tj
0.94384 0.00001 TD
(de olum)Tj
3.24951 0 TD
(suz y\232n)Tj
3.08276 0 TD
[(de etkilenme)-1(mektedir.)]TJ
ET
Q
q
BT
/F0 1 Tf
11 0 0 11 311.811 382.947 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(SONU\202)Tj
ET
Q
q
BT
/F1 1 Tf
11 0 0 11 311.811 354.947 Tm
0 Tr
0 0 0 1 k
0 Tc
0.049 Tw
[(Elektrokoagulas)-1(yon y\232ntemi ile tubal steri)-1(lizasyon)]TJ
0 -1.27273 TD
0.004 Tc
0.121 Tw
[(yap\335l)-1(a)-1(n)-1( h)-1(a)-1(s)-1(ta)-1(lard)-1(a)-1( u)-1(l)-1(tras)-1(o)-1(n)-1(o)-1(g)-1(ra)-1(fik )1(ovaryen )1(rezerv)]TJ
0 -1.27272 TD
0.002 Tc
0 Tw
(be)Tj
0.94751 0.00001 TD
(lir)Tj
0.89392 0.00001 TD
0.123 Tw
[(te\215le)-1(ri olan total bazal ovaryen hacim ve an-)]TJ
-1.84143 -1.27273 TD
0.019 Tc
0.106 Tw
(tral fo)Tj
2.65255 0.00001 TD
[(l)1(i)1(kul say\335)-1(s\335nda preoper)1(a)1(tif ve posto)-1(per)1(a)1(t)1(i)1(f)]TJ
-2.65255 -1.27274 TD
0.01 Tc
0.115 Tw
[(d\232nemler aras\335nda is)-1(tatistiksel olarak anlam)-1(l\335 bir)]TJ
0 -1.27272 TD
0 Tc
0.074 Tw
[(fark izlenmekte)-1(dir. Preoperatif ile pos)-1(toperatif d\232-)]TJ
0 -1.27273 TD
0.006 Tc
0 Tw
(nem)Tj
1.74008 0.00001 TD
(de)Tj
0.95612 0.00001 TD
0.119 Tw
(ki hor)Tj
2.51626 0.00001 TD
0 Tw
(mo)Tj
1.2901 0.00001 TD
0.119 Tw
(nal ovar)Tj
3.41623 0.00001 TD
(yen re)Tj
2.62614 0.00001 TD
(zerv be)Tj
3.07611 0.00001 TD
0 Tw
(lir)Tj
0.90683 0.00001 TD
[(te\215le)-1(rinde)]TJ
-16.52786 -1.27277 TD
0.017 Tc
0.108 Tw
[(b\232yle bir fark\335n g\232r\237lme)-1(mesinin nede)-1(ni ultraso-)]TJ
0 -1.27272 TD
0 Tc
0.121 Tw
[(nografik para)-1(metre)-1(lerin azalan ovaryen rezervi)-1(nin)]TJ
0 -1.27273 TD
0.009 Tc
0 Tw
(da)Tj
0.96154 0.00001 TD
0.116 Tw
(ha er)Tj
2.13086 0.00001 TD
(ken g\232s)Tj
3.26086 0.00001 TD
0 Tw
(ter)Tj
1.08099 0.00001 TD
0.116 Tw
[(geleri ol)-1(malar)1(\335d\335r. Bu bulgular,)]TJ
-7.43426 -1.27275 TD
0.001 Tc
0.124 Tw
[(elekt)1(r)1(o)1(koagul)1(a)1(syon y\232nt)1(e)1(mi ile tubal ster)1(il)1(i)1(zasyo-)]TJ
0 -1.27273 TD
0 Tc
0.123 Tw
(nun pos)Tj
3.26207 0.00001 TD
[(topera)-1(tif d\232nemde over rezervi)-1(ni olumsuz)]TJ
-3.26207 -1.27273 TD
0.119 Tw
[(etkile)-1(yece\333ini g\232s)-1(termektedir. Ancak, bu bulgula)-1(-)]TJ
T*
0.025 Tw
[(r\335n do\333rulanma)-1(s\335 i\215in daha fazla say\335da uzun vade)-1(-)]TJ
0 -1.27272 TD
0 Tw
[(li \215al\335\337ma)-1(lar\335n yap\335lma)-1(s\335 gereklidir.)]TJ
0 -2.54545 TD
0.024 Tw
[(Mekanik klips y\232nte)-1(mi ile tubal sterili)-1(zasyon yap\335-)]TJ
ET
0 0 0 0 k
56.693 789.197 481.89 10.173 re
f
Q
q
BT
/F2 1 Tf
8 0 0 8 57.6929 792.4114 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(N. S\237er ve ark., Tubal sterilizasyonda elektrokoag\237lasyon ve mekanik klips y\232ntemlerinin over rezervine etkilerinin kar\337\335la\337t\335r\335lmas\335)Tj
ET
0 0 0 0 k
521.575 92.544 17.0079 12.338 re
f
Q
q
BT
/F0 1 Tf
10 0 0 10 522.5747 96.4239 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(131)Tj
ET
Q
endstream
endobj
9 0 obj
<<
/Length 10116
>>
stream
/GS0 gs
q
0 0.89 595 841 re
W n
1 g
0 841.89 0 0 re
f
Q
/GS1 gs
q
0 0 0 0 k
56.693 352.0551 481.89 404.796 re
f
Q
q
BT
/F1 1 Tf
11 0 0 11 57.6929 747.2382 Tm
0 Tr
0 0 0 1 k
0.001 Tc
0.124 Tw
[(lan hasta grubunda ise hem hormo)-1(nal hem de ul-)]TJ
0 -1.27273 TD
-0.0003 Tc
(t)Tj
0.27772 -0.00001 TD
0 Tc
0.065 Tw
[(rasonogra)-1(fik ovaryen belirte\215le)-1(ri aras\335nda preope-)]TJ
-0.27772 -1.27272 TD
0.006 Tc
0.119 Tw
[(ratif d\232nem ve pos)-1(toperatif 10. Ayda ista)-1(tistiksel)]TJ
0 -1.27273 TD
0.025 Tc
0.1 Tw
[(bir farkl\335)-1(l\335k tespit edilmemi\337tir. Dola)-1(y\335s\335 ile bu)]TJ
T*
0 Tc
0.024 Tw
[(bulgular mekanik klips y\232nte)-1(mi ile tubal sterili)-1(zas-)]TJ
0 -1.27272 TD
0.006 Tc
0.119 Tw
[(yonun over rezervi)-1(ne olumsuz etkisinin olma)-1<64DDDBDD>]TJ
0 -1.27273 TD
0 Tc
0 Tw
[(\337eklinde yorum)-1(lanmaktad\335r.)]TJ
ET
Q
q
BT
/F0 1 Tf
11 0 0 11 57.6929 635.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(KAYNAKLAR)Tj
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 57.6929 611.2382 Tm
0 Tr
0 0 0 1 k
0.025 Tc
0.1 Tw
(1. Kulier R, Boulvain M, Walker DM, De Candolle G,)Tj
0 -1.11111 TD
0 Tc
0.08 Tw
(Campana A:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 110.6303 601.2381 Tm
0 Tr
0 0 0 1 k
0 Tc
0.08 Tw
[(Minila)-1(parotomy and endoscopic tech)-1(niques for)]TJ
-5.88193 -1.11111 TD
0.085 Tw
[(tubal steri)-1(lisati)-1(on. Cochrane Database of Systema)-1(tic Reviews)]TJ
T*
0 Tw
(2004;3:37.)Tj
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 57.6929 571.2381 Tm
0 Tr
0 0 0 1 k
0 Tc
0.032 Tw
(2. Fernandes AM, Bedone AJ, Leme LC, Yamada EM:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 272.975 571.2381 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(In-)Tj
-23.92023 -1.11111 TD
0.001 Tw
[(trapartum and in)-1(terval tubal sterili)-1(zation. Rev Assoc Med Bras)]TJ
T*
0 Tw
(2006;52:323-7.)Tj
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 57.6929 541.2381 Tm
0 Tr
0 0 0 1 k
0.028 Tc
0.097 Tw
(3. Zurawin RK, Sklar AJ:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 170.5379 541.2381 Tm
0 Tr
0 0 0 1 k
0.028 Tc
0.097 Tw
[(T)1(u)1(bal Ster)1(il)1(i)1(z)1(a)1(t)1(ion. eMed)1(i)1(c)1(i)1(-)]TJ
-12.53833 -1.11111 TD
0 Tc
0 Tw
(ne.com 2006.)Tj
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 57.6929 521.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
0.041 Tw
(4. Tanriverdi HA, Akbulut OV:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 183.7757 521.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
0.041 Tw
[(Laparos)-1(copic and hysteros-)]TJ
-14.0092 -1.11112 TD
0 Tw
[(copic tubal steri)-1(lizati)-1(on. J Surg Med Sci)-250(2006;2:30-7.)]TJ
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 57.6929 501.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
0.1 Tw
(5. Ng EH, Chan CC, Yeung WS, Ho PC:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 223.0484 501.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
0.1 Tw
(Effect of age on)Tj
-18.37283 -1.11111 TD
0.005 Tc
0 Tw
(ova)Tj
1.45765 0 TD
0.004 Tc
(ri)Tj
0.6198 0 TD
0.12 Tw
(an stro)Tj
2.84597 0 TD
(mal flow me)Tj
5.34512 0 TD
0 Tw
(asu)Tj
1.34657 0 TD
0.005 Tc
0.12 Tw
(red by thre)Tj
4.62247 0 TD
0.004 Tc
0.121 Tw
[(edimension)-1(a)-1(l)-1( u)-1(l)-2(tras)-1(o)-1(-)]TJ
-16.23758 -1.11113 TD
0 Tc
0.032 Tw
[(und with power Doppler in Chinese women with pro)-1(ven ferti-)]TJ
0 -1.11111 TD
0 Tw
[(lity. Hum Reprod)-250(2004;19:2132-7.)]TJ
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 57.6929 461.2382 Tm
0 Tr
0 0 0 1 k
0.022 Tc
0.103 Tw
(6. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ,)Tj
0 -1.11112 TD
0 Tc
0.105 Tw
(Nelson JF:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 103.0791 451.2381 Tm
0 Tr
0 0 0 1 k
0 Tc
0.105 Tw
[(Acce)-1(lerated disappe)-1(arance of ovarian follic)-1(les in)]TJ
-5.04291 -1.11111 TD
0.002 Tc
0 Tw
(mid-li)Tj
2.45527 0 TD
0.123 Tw
(fe: imp)Tj
2.99628 0 TD
0 Tw
(li)Tj
0.55938 0 TD
0.123 Tw
[(cati)-1(ons for for)1(e)1(casting me)-1(nopause. Hum Rep-)]TJ
-6.01092 -1.11112 TD
0 Tc
0 Tw
(rod 1992;7:1342-6.)Tj
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 57.6929 421.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
0.093 Tw
(7. Gougeon A:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 117.6888 421.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Re)Tj
1.11085 0 TD
(gu)Tj
1 0 TD
(la)Tj
0.72168 0 TD
0.093 Tw
[(tion of ovari)-1(an follicular dev)-1(elopment)]TJ
-9.49873 -1.11112 TD
0.008 Tc
0.116 Tw
[(in primates: facts and hypot)-1(heses. Endocr Rev1996;17:121-)]TJ
0 -1.11111 TD
0 Tc
0 Tw
(55.)Tj
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 57.6929 391.2382 Tm
0 Tr
0 0 0 1 k
0 Tc
0.059 Tw
(8. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH,)Tj
0 -1.11111 TD
0.116 Tw
(Habbema JD, te Velde ER:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 169.3619 381.2381 Tm
0 Tr
0 0 0 1 k
0 Tc
0.116 Tw
[(Predictors of poor ova)-1(rian res-)]TJ
-12.40766 -1.11111 TD
0.109 Tw
[(ponse in in vitro ferti)-1(lizati)-1(on: a prospective study comparing)]TJ
T*
0 Tw
[(basal markers of ovari)-1(an reserve. Fertil Steril 2002;77:328-36.)]TJ
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 311.811 748.804 Tm
0 Tr
0 0 0 1 k
0.002 Tc
(9)Tj
0.50203 0.00001 TD
(.)Tj
0.62696 0 Td
0.123 Tw
(Alvarez F, Faundes A, Brache V, Tejada AS, Segal S:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 311.811 738.8041 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(P)Tj
0.55586 0.00001 TD
0 Tc
0.081 Tw
[(rospecti)-1(ve study of the pituitary-ovarian)-332(function after tubal)]TJ
-0.55586 -1.11112 TD
0.064 Tw
[(steri)-1(lizati)-1(on by the Pomeroy or Uchida techniques. Fer)-1(til Ste-)]TJ
0 -1.11111 TD
0 Tw
(ril 1989;51:604-8.)Tj
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 311.811 708.8041 Tm
0 Tr
0 0 0 1 k
-0.01 Tc
0.019 Tw
(10. Geber S, Caetano JP:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 409.1603 708.8041 Tm
0 Tr
0 0 0 1 k
-0.01 Tc
0.019 Tw
(Doppler colour flow analysis of ute-)Tj
-10.81659 -1.11111 TD
0.041 Tw
[(rine and ovari)-1(an arteri)-1(es prior to and after surgery for tubal ste-)]TJ
T*
0 Tw
[(rili)-1(zation: a prospecti)-1(ve study. Hum Reprod 1996;11:1195-8.)]TJ
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 311.811 678.8041 Tm
0 Tr
0 0 0 1 k
0.011 Tc
0.114 Tw
(11. Carmona F, Crist\227bal P, Casamitjana R, Balasch J:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 311.811 668.804 Tm
0 Tr
0 0 0 1 k
0.0014 Tc
(E)Tj
0.61243 0.00001 TD
0.002 Tc
0.123 Tw
[(f)1(fect of tubal ste)-1(r)1(i)1(l)1(i)1(za)-1(t)1(i)1(on on ovar)1(i)1(an foll)1(icular reserve and)]TJ
-0.61243 -1.11112 TD
-0.0001 Tc
(f)Tj
0.33287 0.00001 TD
0 Tc
0 Tw
[(unction. Am J Obs)-1(tet Gyn)1(e)-1(col 2003;189:447-52.)]TJ
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 311.811 648.8041 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(1)Tj
0.49993 0.00001 TD
0 Tc
0.048 Tw
(2. Dede FS, Dilbaz B, Akyuz O, Caliskan E, Kurtaran V,)Tj
-0.49993 -1.11112 TD
0.088 Tw
(Dilbaz S:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 350.8912 638.804 Tm
0 Tr
0 0 0 1 k
0 Tc
0.088 Tw
[(Changes in menstrual pattern and ova)-1(rian function)]TJ
-4.34224 -1.11111 TD
0.009 Tc
0.115 Tw
[(following bip)-1(o)-1(lar elec)-1(trocauteri)-1(zation of the fallop)-1(ian tubes)]TJ
T*
0.075 Tc
0.204 Tw
[(for voluntary surgical contra)-1(ception. Contracep)-1(tion)]TJ
T*
0 Tc
0 Tw
(2006;73:88-91.)Tj
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 311.811 598.804 Tm
0 Tr
0 0 0 1 k
0 Tc
0.036 Tw
(13. Kelekci S, Yilmaz B, Yakut Y, Yasar L, Savan K, Son-)Tj
0 -1.11111 TD
0.102 Tw
(mez S:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 341.6297 588.8041 Tm
0 Tr
0 0 0 1 k
0 Tc
0.102 Tw
[(Hormonal and ovari)-1(an stromal blood supply changes)]TJ
-3.31319 -1.11111 TD
0.1 Tw
[(after la)-1(paroscopic tubal steri)-1(lizati)-1(on: a prospective controlled)]TJ
T*
0 Tw
[(study.)-250(Contracepti)-1(on)-250(2006;73:279-83.)]TJ
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 311.811 558.804 Tm
0 Tr
0 0 0 1 k
0 Tc
0.032 Tw
(14. Belaisch-Allart J, Mayenga JM, Castaing N, Allart JP:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 311.811 548.804 Tm
0 Tr
0 0 0 1 k
0.013 Tc
0.112 Tw
[(Is tubal and uter)1(ine surgery del)1(e)1(t)1(e)1(rious to)-376(ovar)1(i)1(an reserve?)]TJ
0 -1.11112 TD
0 Tc
0 Tw
(Gynecol Obstet Fertil 2006;34:1111-7.)Tj
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 311.811 528.804 Tm
0 Tr
0 0 0 1 k
0.014 Tc
0.111 Tw
(15. Flaws JA, Langenberg P, Babus JK, Hirshfield AN,)Tj
0 -1.11111 TD
0 Tc
0.075 Tw
(Sharara FI:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 361.1558 518.804 Tm
0 Tr
0 0 0 1 k
0 Tc
0.075 Tw
[(Ovari)-1(an volume and antral follicle counts as in-)]TJ
-5.48275 -1.11111 TD
0 Tw
[(dicators of me)-1(nopausal status. Menopause 2001;8:175-80.)]TJ
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 311.811 498.804 Tm
0 Tr
0 0 0 1 k
0 Tc
0.032 Tw
(16. Timonen S, Tuominen J, Irjala K, M\212enp\212\212 J: )Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 508.6006 498.804 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
[(Ovari)-1(an)]TJ
-21.86551 -1.11112 TD
0.003 Tc
0.122 Tw
[(function and re)-1(gulation of the hypothala)-1(micpituitary-ovari)-1(an)]TJ
0 -1.11111 TD
0 Tc
0 Tw
(axis af)Tj
2.63721 0 TD
(ter tu)Tj
2.08228 0 TD
(bal ste)Tj
2.58226 0 TD
[(rili)-1(zation. J Reprod Med 2002;47:131-6.)]TJ
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 311.811 468.804 Tm
0 Tr
0 0 0 1 k
0 Tc
0.001 Tw
(17. Thranov I, Hertz JB, Kjer JJ, Andresen A, Micic S, Ni-)Tj
0 -1.11111 TD
0.029 Tw
(elsen J, Hancke S: )Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 385.0984 458.804 Tm
0 Tr
0 0 0 1 k
0 Tc
0.029 Tw
[(Hormonal and menstru)-1(al changes after la-)]TJ
-8.14304 -1.11111 TD
0.048 Tw
[(paroscopic ste)-1(riliza)-1(tion by Falope-rings or Filshie-clips. Fer)-1(til)]TJ
T*
0 Tw
(Ste)Tj
1.27759 0 TD
(ril 1992;57:751-5.)Tj
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 311.811 428.804 Tm
0 Tr
0 0 0 1 k
0.007 Tc
0.117 Tw
(18. Sumiala S, Pirhonen J, Tuominen J, M\212enp\212\212 J:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 526.957 428.804 Tm
0 Tr
0 0 0 1 k
0.007 Tc
0 Tw
(In-)Tj
-23.90511 -1.11111 TD
0 Tc
0.018 Tw
[(creased uteri)-1(ne and ovarian vascular re)-1(sistance following Fils-)]TJ
T*
0 Tw
(hi)Tj
0.77783 0 TD
-0.0001 Tc
(e)Tj
0.7508 0 Td
0 Tc
0.057 Tw
[(clip steri)-1(lization: pre)-1(liminary findings obtai)-1(ned with color)]TJ
-1.52863 -1.11112 TD
0 Tw
[(Doppler ultraso)-1(nography. J Clin Ultrasound 1995;23:511-6.)]TJ
ET
Q
q
BT
/F0 1 Tf
9 0 0 9 311.811 388.804 Tm
0 Tr
0 0 0 1 k
0 Tc
0.033 Tw
(19. Baloglu A, Uysal D, Karci L, Guven CM, Yavuz E:)Tj
ET
Q
q
BT
/F1 1 Tf
9 0 0 9 526.0955 388.804 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Ef)Tj
0.94359 0 TD
(-)Tj
-24.75299 -1.11111 TD
0.051 Tw
[(fects of laparosco)-1(pic tubal ligation on ovari)-1(an blood flow and)]TJ
T*
0 Tw
(ste)Tj
1.1106 0 TD
(ro)Tj
0.83277 0 TD
[(idogenesis. Clin Exp Obstet Gyne)-1(col 2005;32:230-2.)]TJ
ET
0 0 0 0 k
402.52 789.197 136.063 10.173 re
f
Q
q
BT
/F2 1 Tf
8 0 0 8 403.5198 792.4114 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(G\232ztepe T\335p Dergisi 23(4):126-132, 2008)Tj
ET
0 0 0 0 k
56.693 92.544 17.008 12.338 re
f
Q
q
BT
/F0 1 Tf
10 0 0 10 57.6929 96.4236 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(132)Tj
ET
Q
endstream
endobj
10 0 obj
<<
/Nums[0<>]
>>
endobj
11 0 obj
<<
/Differences[32/space 40/parenleft/parenright/asterisk 44/comma/hyphen/period 48/zero/one/two/three/four/five/six/seven/eight/nine/colon 65/A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P 82/R/S/T/U/V/W/X/Y/Z 97/a/b/c/d/e/f/g/h/i/j/k/l/m/n/o/p 114/r/s/t/u/v/w 121/y/z 130/Ccedilla 133/Odieresis/Udieresis 138/adieresis 141/ccedilla 151/oacute 154/odieresis 159/udieresis 177/plusminus 218/fraction/currency/guilsinglleft/guilsinglright/fi/fl]
/BaseEncoding/MacRomanEncoding
/Type/Encoding
>>
endobj
12 0 obj
<<
/Subtype/Type1C
/Length 10525
/Length1 10525
>>
stream
JPBISX+TimesTurkB ?ø øøøøRû”ú„úY
‹‹
‹‹ ¹ µ ^‘ ) %DNMacromedia Fontographer 4.1.5 4/1/99Generated by Fontographer 4.1.5TimesTurkB Q 5 V C B M T U F S J [ Z P O E L H à W N Q Ú n l / D 4 Ã &